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Abstract 
 
Mycobacterial infections are a health problem worldwide with Mycobacterium tuberculosis, 
the causative agent of tuberculosis, being responsible for over one million deaths every year. 
The opportunistic pathogen Mycobacterium avium is another member of the mycobacteria 
family, mainly causing disease in immunocompromised patients. The treatment of 
mycobacterial infections is extensive, and the emergence of mycobacterial strains resistant to 
the current treatments presents an urgent need for development of new treatments and 
effective vaccines.  
KEAP1 is an oxidative stress sensor with several binding partners in the cell. Research 
in our group has shown that KEAP1 negatively regulates the induction of pro-inflammatory 
cytokines and autophagy in response to M. avium infection in primary human macrophages. 
The mechanism of how this regulation occurs is not understood, and has been under 
investigation in this thesis. HEK293 cells were tested out as a model for our investigation and 
were proved to be unsuitable for our purpose. The investigation of how KEAP1 negatively 
regulates inflammatory responses following M. avium infection was therefore carried out in 
primary human macrophages. Findings obtained throughout this study show that the E3 
ubiquitin ligase complex proteins Cul3 and Rbx1 associated with KEAP1 might have an 
important role in the negative regulation of inflammation seen following M. avium infection.  
Mycobacterial infections and innate immune receptor signalling can affect antigen-
presentation. Since KEAP1 appears to be involved in anti-mycobacterial responses in primary 
human macrophages, we investigated the role of KEAP1 in regulation of antigen presentation 
and shaping of the following adaptive immune response. Using siRNA knockdown of KEAP1 
in primary human macrophages, we obtained evidence suggesting that KEAP1 positively 
influences macrophage expression of the molecules CD80 and HLA-DR, both important for 
the activation of the adaptive CD4+ T cell response. How this alteration changes the 
following adaptive immune response is not known. We therefore wanted to establish an assay 
with expanded human mycobacteria-specific T cells in order to analyse whether or not 
KEAP1 affects the activation of mycobacteria-specific TH1 cells upon stimulation with M. 
avium infected autologous macrophages. T cells survived the expansion and produced 
cytokines upon stimulation with a positive control (stimulation cocktail). However, 
preliminary experiments did not allow us to establish a solid protocol to analyse activation of 
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mycobacteria-specific T cells upon stimulation with primary human macrophages. More 
experiments are hence necessary to optimise this assay.  
This thesis has increased our knowledge of how KEAP1 is involved in the innate immune 
response in primary human macrophages. Future experiments should aim to verify and further 
elaborate on the findings done in this thesis, as well as continue the work on investigating the 
links to adaptive immunity.   
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1 Introduction 
1.1 Mycobacterial infections 
Mycobacterial infections are a health problem worldwide, with Mycobacterium tuberculosis, 
the causative agent of tuberculosis causing 1.3 million deaths in 2012
1
. Although the numbers 
of new cases and mortality rates have decreased for the last two decades, the global burden 
remains high with approximately 8.6 million new cases in 2012
1
. This makes tuberculosis one 
of the leading causes of death worldwide and it is the main cause of death in human 
immunodeficiency virus (HIV) infected individuals living in Africa
2
. M. tuberculosis most 
commonly affects the lungs, causing pulmonary tuberculosis, but can also affect other parts of 
the body. Infected individuals that do not show symptoms of disease are said to have a latent 
infection. In these individuals the immune response effectively inhibits disease, although the 
bacteria might not be eradicated. At this stage the disease is hard to diagnose. If an individual 
gets immune-compromised, the risk of reactivation increases, as exemplified in patients co-
infected with HIV
3
.  
The route of infection of M. tuberculosis is through inhalation of droplets containing 
the pathogen. Upon inhalation phagocytic cells at the epithelial surface of the lungs engulf the 
bacteria, mainly alveolar macrophages at this stage. Immune cells are activated and release 
chemokines to attract more immune cells, including dendritic cells (DCs), neutrophils, natural 
killer (NK) cells, and monocyte derived macrophages (MDMs). The immune cells are not 
able to stop the bacterial proliferation, and recruitment of innate immune cells allows the 
expanding mycobacterial population in the lung to spread from cell to cell. The innate 
immune response engages the adaptive immune response, specifically T cells, although there 
is a delay in this recruitment
4-6
. Once the adaptive immune response is established, there is a 
halt in the growth of the bacterium, but the infection is in most cases not eradicated. At this 
stage most people become asymptomatic, and are said to have a latent infection
6
. A 
granuloma is a characteristic feature of latent infection, and is formed during the immune 
response. The granuloma is an infiltrate consisting of an array of mononuclear immune cells, 
and gives a niche for the bacteria to reside in. It forms as a result of the immune cells not 
being able to eradicate the pathogen, and instead accumulate around the infection to avoid 
further spread. The granuloma is organised, and has a central core of macrophages, that is 
surrounded by lymphocytes, as well as DCs, endothelial cells, fibroblasts, and granulocytes
3,5
. 
Within the granuloma, M. tuberculosis enters a state where replication is very low, but the 
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bacteria are still able to generate energy and hence survive
5
. If the immune system of the host 
is weakened, for reasons such as HIV infection or immunosuppressive treatment, the bacteria 
can get reactivated and return to a virulent state where it can once again cause disease
6
. 
Figure 1.1 illustrates the stages of M. tuberculosis infection from inhalation to reactivation. 
 
Figure 1.1: The stages of M. tuberculosis infection.Upon inhalation M. tuberculosis is engulfed by 
alveolar macrophages at the epithelial surface of the lung. The proinflammatory response triggered 
leads to recruitment of more immune cells. Macrophages in the forming granuloma can differentiate to 
epithelioid cells, multinucleated giant cells, and foam cells. A fibrous cap can form around the 
granuloma, in the same area where the lymphocytes are also mainly found. Upon reactivation the 
granuloma destabilises, and previously contained bacteria are released into the lung
7
. 
Mycobacterium avium, a member of the M. avium complex (MAC), is another 
member of the mycobacteria family. This is a nontuberculous, opportunistic pathogen mainly 
causing disseminated infection in immunocompromised patients
8
. Lung infections with M. 
avium are not associated with immunodeficiency, but rather other lung conditions such as 
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chronic obstructive pulmonary disease and cystic fibrosis
9,10
. As opposed to M. tuberculosis, 
M. avium is an environmental pathogen. The main source of exposure to M. avium is through 
water, in particular drinking water. Another source of exposure is through soil
11
. 
Environmental bacteria, including M. avium and other nontuberculous mycobacteria have 
adapted to diverse and harsh conditions such as low oxygen tension, low nutrition levels, and 
acidic environments. Such adaptions often aid the virulence of these bacteria
11,12
.    
The current vaccine used against tuberculosis is the Mycobacterium bovis Bacillus 
Calmette-Guérin (BCG) vaccine. BCG is efficient in protecting children against early 
manifestations of tuberculosis, but fails to protect against adult pulmonary tuberculosis
13
.  
The current treatment for tuberculosis consists of several antibiotics taken over a period of 6 
months or more
7
. Multidrug-resistant (MDR) and extensively drug-resistance (XDR) strains 
have emerged, which are no longer susceptible to the current drugs used to treat 
tuberculosis
14
. Thus there is an urgent need for new and better vaccines and treatments than 
what currently exists. 
To be able to develop new vaccines and treatments, we need a better understanding of 
how the mycobacterial pathogens interacts and evades the immune system, and what can be 
done to overcome mycobacterial evasion mechanisms. 
1.2 The innate immune system in mycobacterial infection 
The innate immune system is the first line of defence against invading pathogens, including 
mycobacteria. It includes physical barriers such as the skin and mucosal surfaces, immune 
cells such as neutrophils, macrophages, NK cells, and DCs, as well as the complement 
system. The innate immune cells recognise foreign substances through germ-line encoded 
pattern recognition receptors (PRRs) which recognise and bind to structures common to many 
pathogens that are not normally present in our body. These structures are called pathogen-
associated molecular patterns (PAMPs). Damaged self-cells can also be recognised, through 
damage-associated molecular patterns (DAMPs)
15
. The macrophage response to 
mycobacterial infections will be the focus of this thesis.  
Macrophages play an important role in the defence against invading pathogens, in 
maintenance of tissue homeostasis, clearance of damaged self-cells, as well as in recruitment 
and instruction of cells of the adaptive immune system. They originate from myeloid 
progenitor cells in the bone marrow, which through several developmental steps become 
monocytes which are released into the blood stream. The monocytes can then migrate into 
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tissues where they further develop into long-lived tissue-specific macrophages
16
. When a 
macrophage encounters a pathogen, the invading pathogen is phagocytosed and processed, 
and antigens are presented on the cell surface via the major histocompatibility complex 
(MHC) class I and II. MHC class I molecules are present on the surface of almost all cells in 
the body, while MHC class II molecules are found on antigen presenting cells (APCs). 
Production of chemokines and presentation of antigens is required for the recruitment and 
activation of cells of the adaptive immune system
17
. 
Upon stimulation, macrophages get activated and develop into effector macrophages. 
During a cell-mediated response, macrophages are activated through cytokines such as 
interferon γ (IFNγ) and tumor-necrosis factor α (TNFα). This activation leads to macrophages 
with increased microbicidal activity producing high levels of pro-inflammatory cytokines. 
The activating cytokines can thereby originate from other APCs or from T cells
16
.   
M. tuberculosis can evade or even take advantage of the host’s cellular response to an 
infection. Both adaptive and innate immunity can be evaded through mechanisms like 
inhibition of phagosome maturation, resistance to microbicidal and cytokine defences, and 
inhibition of antigen presentation
18
.  
1.2.1 Pattern recognition receptors 
PRRs on the surface of APCs include Toll-like receptors (TLRs), Nod-like receptors (NLRs), 
C-type lectin receptors (CLRs), RIG-1 like receptors (RLRs), as well as cytocolic DNA 
sensors
19
. In mycobacterial infection host macrophages and dendritic cells phagocytose the 
microbe at the site of infection. It is the PRRs on the surface of host APCs that recognise 
structures on the pathogen, leading to phagocytosis
19
.   
The TLRs is a group of 10 PRRs in humans. They are found both on the plasma 
membrane and on intracellular membranes and play an important role in recognition of both 
intracellular and extracellular ligands
19
. Especially three TLRs; TLR2 and TLR4 which are 
found on the plasma membrane, and TLR9 located in endosomes, have been shown to play 
important roles in recognition and response to mycobacterial infection in macrophages
19-21
. 
Upon recognition, the TLRs rapidly induce intracellular signals leading to activation of the 
mitogen-activated protein kinase (MAPK) and nuclear factor-κB (NF-κB) pathways, which 
both play important roles in in the innate immune defence through the generation of 
antimicrobial effector molecules
20
. The production of type I IFNs is also initiated, through 
activation of TANK-binding kinase 1 (TBK1) and interferon regulatory factors (IRFs)
22
. The 
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TLR signalling pathway is shown in Figure 1.2. The NF-κB transcription factor is normally 
found in the cytoplasm bound to IκB regulatory proteins. When the cell is activated, IκB is 
degraded and the transcription factor is able to enter the nucleus and transcribe target genes. 
In most cases it is the IκB kinases (IKKs) that targets IκB for degradation. NF-κB target many 
genes encoding pro-inflammatory cytokines and chemokines
23, including TNFα, and 
interferon gamma induced protein 10 (IP-10), while activation of IRFs leads to the production 
of IFNβ24.  
 
Figure 1.2: TLR signalling pathways involved in mycobacterial recognition  TLR2 and TLR4 
recognise ligands outside the cell, while TLR9 recognise bacterial DNA. Myeloid differentiation 
primary response gene 88(MyD88) is a common adaptor protein for all these TLRs and lead to 
activation of NF-κB and transcription of inflammatory cytokines. TLR4 can also signal in a MyD88 
independent way, through adaptor protein TRIF, activating IRFs and transcription of IFN-β25. 
CLRs are membrane bound receptors that recognise carbohydrate-rich molecules and 
are important for phagocytosis of mycobacterial pathogens.  The four CLRs mannose 
receptor, DC-SIGN, mincle and Dectin-1 are closely associated with responses to 
mycobacteria
19,21
. The primary way of phagocytosis of M. tuberculosis in human 
macrophages is through recognition by mannose receptors, and this process is also associated 
with an anti-inflammatory program. The mannose receptors recognise lipoarabinomannan 
(LAM) and mannocylated LAM (ManLAM), which are glycolipids that are found on the cell 
wall of mycobacteria as well as on other microbes
19
. Dectin-1 has been shown to play an 
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important role in the recognition and ingestion of the fungal cell wall derivative β-glucan. 
Recognition of β-glucans by this receptor contributes to phagocytosis, reactive oxygen species 
(ROS) production, and cytokine production in macrophages
21,26-28
.  
Studies have shown that Dectin-1 and TLR2 can collaborate in the initiation of an 
inflammatory response, and that Dectin-1 expression enhances the activation of the NF-κB 
pathway initially activated by TLR2, in response to β-glucan particles28,29. The ROS 
production following recognition of these particles is independent of TLR2
29
. Much of the 
research addressing Dectin-1 has been focused on immune responses to fungi, but the receptor 
is also involved in immune responses against mycobacteria. Yadav and Schorey 
26
 showed 
that Dectin-1 and TLR2 also cooperate in macrophage activation following mycobacterial 
infections in murine macrophages. Their data suggest that Dectin-1 serves to increase the 
TLR2-dependent inflammatory response, measured through MAPK activation and TNFα 
production in macrophages following infection with non-pathogenic mycobacteria. However, 
they did not see the same response following infection with pathogenic strains. Although 
evidence suggests that TLR2 is an important TLR in the recognition and defence against 
mycobacteria, the pathogen is also able to use this receptor for its own advantage and survival 
within host cells. Research suggests that M. tuberculosis can use TLR2 to decrease antigen 
presentation via MHC II, and hence decrease the adaptive immune response
18
. 
Cytosolic DNA sensors have been shown to get activated upon M. tuberculosis 
infection in murine macrophages, as the bacteria can partially permeabilize the phagosomal 
membrane
30
. This activation leads to signalling through the Sting/Tbk1/Irf3 pathway, and 
results in production of IFNβ30. Emerging evidence also suggest a link between the sensing of 
cytosolic DNA and autophagy
31
. The mechanisms of inflammatory regulation in 
mycobacterial infections are starting to get unravelled, but much is still unknown.  
1.2.2 Autophagy  
Macroautophagy (hereafter referred to as autophagy) is a catabolic process where the cell 
wraps a double layered membrane around intracellular cargo, forming an autophagosome, 
which is then delivered to lysosomes for degradation. This is a process that is used by the cell 
to degrade cellular components as well as protection against intracellular pathogens
32
. The 
principle of autophagy is shown in Figure 1.3.  
Autophagy has important roles in both the adaptive and innate immunity. It is involved 
in shaping the adaptive immune response through its role in thymic selection and homeostasis 
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of T cells, antigen presentation, and polarisation of T helper (TH) 1 and TH2 cells. In 
macrophages, autophagy protects the cells against bacterial toxins, aids in the activation of the 
cell, and can directly kill intracellular pathogens
32
. A common marker to recognise 
autophagosomes in mammalian cells is the microtubule-associated 1A/1B-light chain 3 
(LC3). LC3 exists in two states, soluble LC3I, or membrane bound LC3II, and it is the latter 
which is found in the membrane of autophagosomes and is used as a marker for autophagy
33
. 
 
Figure 1.3: General overview of autophagy.  Autophagy can break down both cellular components 
and invading pathogens. A membrane structure called a phagophore wraps around the target cargo, 
forming a double membrane autophagosome. The incorporation of cargo can be non-selective (bulk 
autophagy) or selective (selective autophagy). Selective autophagy is mediated through cargo 
receptors such as p62. NBR1, NDP52, and optineurin which bind substrates targeted for autophagy 
and bring them to the forming autophagosome through interaction with LC3 II. The autophagosome 
matures upon fusion with lysosomes, and the cargo is degraded. Figure modified from Rubinsztein, et 
al. 
34
.   
Several bacteria, including mycobacteria, have developed mechanisms to avoid killing 
by autophagy. Some bacteria and viruses can even use the autophagosome for their own 
advantage, for replication and spread
35
. M. tuberculosis can survive within autophagosomes in 
macrophages by inhibiting the phagosomal-lysosomal fusion
36
. As autophagy can contribute 
to antigen presentation of peptides derived from intracellular pathogens
37
, mycobacteria might 
thus effectively inhibit presentation of antigens and initiation of the adaptive immune 
response. Gutierrez, et al. 
38
 showed that induction of autophagy, either by starvation or 
pharmaceutically by rapamycin, led to phagosomal maturation, and co-localisation of the 
mycobacterial phagosome with LC3.  Induction of autophagy was shown to decrease the 
intracellular survival of mycobacteria.  
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Jagannath, et al. 
39
 showed that induction of autophagy can enhance the vaccine 
efficacy against tuberculosis in a mouse model. They found that autophagy induced by 
rapamycin enhanced the presentation of the dominant mycobacterial antigen Ag85B via the 
MHC II pathway on APCs. The antigen is associated with the mycobacterial cell wall, but is 
also secreted into the cytosol of the infected host cell. This study also found that the viability 
of the mycobacteria was significantly reduced when autophagy was induced
39
.  
The interplay between autophagy and inflammation, and their regulation of each other 
has gained more attention in the later years. Proinflammatory cytokines can induce 
autophagy, while autophagy can positively or negatively regulate the transcription of 
proinflammatory cytokines
40
. Evidence also suggests that antituberculosis drugs promote 
autophagy through the generation of ROS in the infected cells
40
. However, the mechanisms of 
interaction between autophagy and inflammation are many and complex, and much is still to 
be learned. 
1.2.3 The KEAP1-NRF2 pathway 
Many mechanisms are applied by a macrophage infected with mycobacteria in order to kill 
the invading pathogen. Production of ROS is one such mechanism, although pathogenic 
mycobacteria are relatively ROS resistant
41,42
. Uncontrolled levels of ROS can be damaging 
to cells, and the cell itself has strategies to modulate these levels. Kelch-like ECH-associated 
protein 1 (KEAP1) is a sensor for ROS, and plays an important role in protection against 
oxidative and xenobiotic damage through regulation of the transcription factor Nuclear Factor 
Erythroid-2-related Factor 2 (NRF2). NRF2 target genes are involved in glutathione 
synthesis, elimination of ROS, detoxification of xenobiotics, and drug transport. Under 
normal conditions KEAP1 is bound to NRF2, which is polyubiquitinated and rapidly 
degraded in a 26S proteasomal dependent manner
43,44
. Generally, ubiquitination is carried out 
by a complex of 3 partners: E1, E2, and E3. E1 is the ubiquitin activating enzyme and E2 is 
the ubiquitin carrier protein (conjugating enzyme). The E3 ubiquitin-protein ligase enzyme 
serves to recognise the target substrate and is required for polyubiquitination
45
. The KEAP1 
protein in itself is not responsible for the ubiquination of NRF2, but it is a substrate adaptor 
protein that recruits NRF2 to the Cullin3 (Cul3)-based E3 ubiquitin ligase system. In this 
system Cul3 is a subunit of the E3 ligase enzyme and its interaction partner ring-box 1 (Rbx1) 
is the E2 conjugating enzyme
46
.  
The KEAP1 protein has several cysteine residues which contain reactive thiol groups. 
Upon oxidative or electrophilic stress these thiol residues are modified, leading to a decrease 
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in the E3 ligase activity of KEAP1 and hence stabilisation of NRF2. This stabilisation allows 
the transcription factor to translocate into the nucleus and activate transcription of its target 
genes
44
. Katoh, et al. 
47
 demonstrated the role of KEAP1 in NRF2 regulation by showing that 
under homeostatic conditions, the half-life of NRF2 went from 20.2 minutes in the absence of 
KEAP1, to 11.5 minutes in the presence of KEAP1. In a NRF2 mutant where the binding site 
for KEAP1 was altered, the presence or absence of KEAP1 did not affect the half-life of the 
transcription factor. The level of NRF2 mRNA was not significantly increased when the level 
of the protein increased, which suggests that it is the stabilisation of existing protein upon 
oxidative stress, rather than an increased transcription that leads to NRF2 accumulation in the 
cell
48,49
. Other mechanisms suggested to contribute to regulation of NRF2 levels in the cell 
include autoregulation, microRNAs, phosphorylation/acetylation, protein stability, and 
cysteine modifications on NRF2
50
.   
Figure 1.4 shows the different domains on KEAP1 and NRF2 and the function the 
different domains have in the protein. KEAP1 is believed to function as a homodimer where 
two KEAP1 proteins interact with one NRF2 protein. The Neh2 domain on NRF2 binds to the 
DC domain of KEAP1
44
. There are two motives on the Neh2 domain, DLG and ETGE which 
both binds to KEAP1 via the DC domain in a similar manner, but with different binding 
affinities. The hinge and latch hypothesis suggests that ETGE, which has a higher affinity, 
binds first and functions as a hinge, while DLG has lower affinity and functions as a latch in 
the binding of NRF2 to KEAP1
51
. Cul3 interacts with the IVR and BTB regions on KEAP1
46
.  
 
 
Figure 1.4: Domain structure of NRF2 and KEAP1.  NRF2 consist of 6 NRF2-ECH homology 
(Neh) domains, where Neh2 is the binding domain for KEAP1. KEAP1 has an N-terminal region 
(NTR), a BTB region, a intervening region (IVR), a DC domain, and a C-terminal domain (CTR). The 
DC domain serves as the binding site for NRF2, and the BTB and IVR regions serve as binding site 
for Cul3
44
. 
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Another substrate that interacts with KEAP1 is the mammalian sequestosome 1 
(p62/SQSTM1, hereafter referred to as p62), which is able to disturb the binding between 
KEAP1 and NRF2, and hence activates transcription of NRF2 target genes
43
. p62 protein has 
various roles in the cell and is amongst others involved in the selective autophagy where it 
serves as a cargo receptor. p62 binds ubiquitin on proteins that have been targeted for 
degradation, and brings them into forming autophagosomes via association with LC3II
43,50
. 
Komatsu, et al. 
52
 showed that p62 stabilises NRF2 in autophagy-deficient mice and hence 
leads to transcription of NRF2 target genes. p62 has a KEAP1-interacting region (KIR) that is 
conserved across species and binds to the DC domain on KEAP1, the same region where the 
NRF2 Neh2 region interact. The binding affinity of p62 to KEAP1 makes it able to compete 
with NRF2 for the binding site of the low affinity DLG motif, but not the high affinity ETGE 
motif
52
. When p62 binds to KEAP1, NRF2 is released and free to translocate to the nucleus 
and transcribe its target genes. The affinity of p62 to KEAP1 is also markedly increased when 
p62 is phosphorylated on S351, a serine residue found in KIR domain of the protein
53
. This 
increased affinity leads to activation of NRF2 and degradation of KEAP1 by autophagy. 
Much research on the KEAP1 pathway has focused on its implications in cancer, as 
mutations in KEAP1 have been found in various cancer types
44
. These mutations can lead to 
the constant activation of NRF2, which in turn can lead to resistance to anti-cancer drugs as 
well as cell proliferation. Less focus has been given to the role of KEAP1 in other diseases, 
including inflammation and infection. However, recent research has started to focus more on 
the role of this pathway in relation to infectious diseases, including mycobacterial infections. 
KEAP1 has been shown to have other roles in addition to the regulation of NRF2. Lee, 
et al. 
54
 showed that KEAP1 functions as a Cul3-based E3 ubiquitin ligase for IKKβ and 
hence downregulates the NF-κB signalling by targeting IKKβ for proteasomal degradation. 
IKKβ contains an ETGE motif, similar to other substrates that bind KEAP1, and interact with 
the DC domain on KEAP1
54
. NF-κB is a transcription factor whose target genes include genes 
involved in the immune response, cell proliferation, angiogenesis, cell survival, metastasis, 
and more.  
Data from our group shows that knocking down KEAP1 increases the production of 
NF-κB and IRF regulated cytokines as well as autophagy in response to infection with M. 
avium in primary human macrophages
55
. The intracellular survival of M. avium decreased 
following knockdown of KEAP1, suggesting that the protein is beneficial for the survival of 
mycobacteria within the macrophage. The exact mechanism behind this KEAP1-mediated 
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regulation of mycobacterial infections and what interacting partners of KEAP1 are involved is 
not yet understood. Preliminary unpublished results from our group also indicate that KEAP1 
may influence antigen-presentation and T cell immunity to M. avium infections. 
1.3 Adaptive immunity in mycobacterial infection 
The innate immune system is the first defence when we are exposed to pathogens. This 
response is in some cases enough to stop the infection and kill the microbe. In many cases, 
however, there is a need for the adaptive immune system to participate in the defence. Cells of 
the adaptive immune system are central in the control of mycobacterial infections
56
. The 
innate immune cells phagocytose bacteria or other invading pathogens and recruit adaptive 
immune cells through cytokine production and antigen presentation. We can hence say that 
the adaptive immune response is shaped by the innate response.  
The adaptive immune system consists of T-lymphocytes and B-lymphocytes, also 
referred to as T cells and B-cells. The T cells arise from hematopoetic progenitor cells in the 
bone marrow, before they migrate to the thymus where they develop into immunocompetent 
naïve T cells. In the thymus, T cell progenitors (thymocytes) go through a developmental and 
selective process where they develop T cell receptors (TCRs) that are specific for one antigen. 
All mature T cells express cluster of differentiation (CD)3 on the surface of the cell, and the 
major subsets in addition express either CD4 or CD8 (termed CD4+ and CD8+, respectively). 
CD8+ T cells recognise antigens presented on MHC class I, while CD4+ T cells recognise 
antigens presented on MHC class II.  After development, T cells migrate to the secondary 
lymphoid organs such as the lymph node and spleen, where they can interact with antigens. 
Antigens are only recognised when presented by a MHC molecule on the surface of a host 
cell
57
. T cell-APC interaction involves many molecules, and an immunological synapse is 
formed at the interphase between the two cells (Figure 1.5)
58
. Two signals are required for a 
productive immune response to occur. The first signal is when the TCR recognises a peptide 
presented via a MHC molecule on APCs. The second signal occurs when the co-stimulatory 
molecule CD28 on the T cell interacts with co-stimulatory molecules CD80 or CD86 on 
APCs
59
.  
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Figure 1.5: The immunological synapse.  The interaction between a T cell and an APC involves 
many molecules, both stimulatory and inhibitory. The stimulatory molecules are shown in red, 
activating/co-stimulatory molecules are shown in red, and inhibitory molecules are shown in yellow. 
Figure modified from Huppa and Davis 
58
. 
After activation by encountering a specific antigen, T cells differentiate into effector 
cells, and some cells survive as long lived memory cells. This memory allows for a rapid 
immune response upon subsequent exposure to the same antigen. CD4+ T cells have a helper 
function, and have been termed TH cells. There are several subsets of TH cells, differing in the 
panel of cytokines they produce. TH1 cells produce cytokines that drive cell mediated 
responses such as activating mononuclear phagocytes, NK cells and cytotoxic T cells 
important for killing of intracellular pathogens. TH2 cells produce cytokines enhancing the 
antibody production from B-cells. Other subsets include TH17 which has roles in induction of 
inflammatory responses and autoimmunity, and TREG cells which dampens the immune 
response
57
. CD8+ T cells are circulating cells, and act to remove cells harbouring intracellular 
pathogens, cells infected with viruses, and cells that have been transformed. The CD8+ T 
cells mainly recognise cytosol-derived antigens
57
. 
T cells, in particular CD4+ TH1 cells, are required for the protective immunity against 
pathogenic mycobacteria such as M. tuberculosis
56,60
. TH1 cells produce a range of cytokines, 
including IFNγ, TNFα, and IL2 aiding the phagocytic cells in killing pathogens57. Upon 
infection with mycobacteria, a balanced activation of CD4+ as well as CD8+ T cells seems to 
be important to gain control of the intracellular bacteria
61
.  
B-cells arise from hemopoietic stem cells in the bone marrow and are the source of 
humoral immunity. These cells develop into plasma cells that produce antibodies upon signals 
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from T cells or other immune cells
57
. Most research on the role of the adaptive immune 
system in response to mycobacterial infections has focused on the role of T cells, as will be 
the focus of this thesis. However, there is also increasing interest in the role of B-cell 
mediated immunity in relation to mycobacterial infection
62,63
.  
1.4 Cytokines in mycobacterial infection 
Cytokines produced both by innate and adaptive immune cells have varying roles in the 
response to mycobacterial infections, both in limiting and enhancing the growth and survival 
of bacteria. IFNγ is a type II IFN and is a pro-inflammatory cytokine. It is recognised by cells 
through IFNγ receptor (IFNγR), and is one of the key activators of macrophages, with an 
important role in immune response to mycobacteria and other intracellular pathogens
64
. This 
cytokine is produced by CD4+ T cells, as well as other cells in the body. Although other 
immune cells can also produce IFNγ, evidence suggests that the production from T cells is 
essential for long term control of mycobacterial infection
65
. IL12 is produced by innate 
immune cells following stimulation of TLRs, and deficiency in this cytokine or its receptor is 
observed to result in an increased susceptibility to disease. It has been shown to be important 
for DC migration to the lymph node and T cell activation. Also, there is a reduction in T cells 
producing IFNγ in IL12 deficient mouse models66. IP10 is a chemokine produced in response 
to IFNγ in many cell types, including macrophages. This cytokine works as a chemoattractant 
for other immune cells. Infusion of the type I IFN IFNβ showed a decrease in bacterial 
survival in M. avium infection, but the opposite was seen in infections with M. tuberculosis
64
. 
Production of IL10 on the other hand is beneficial for mycobacterial survival. This is an anti-
inflammatory cytokine that aids the blockage of phagosomal maturation, seen both for 
virulent and attenuated strains of mycobacteria, and leads to enhanced bacterial survival and 
replication
67
. It has also been shown that type I IFNs can induce the expression of IL10. This 
might explain why these IFNs can be beneficial to pathogenic mycobacteria
64,68,69
. TNFα is a 
cytokine produced by both innate and adaptive immune cells, and is recognised by the TNFα 
receptor on the plasma membrane. TNFα plays several roles in a cell, including roles in 
apoptosis, activation, recruitment, and differentiation
70
. Evidence for a role of this cytokine in 
protection against mycobacteria has been present for a long time. Infusion of TNFα has 
showed increased resistance to infection with both M. tuberculosis and M. avium, and both 
the cytokine itself and its receptor have been shown essential for protection against M. 
tuberculosis in mice
71. TNFα also has a role in the granulomas. It is not needed for the 
formation of the granuloma, but for the stability through limiting bacterial replication within 
the macrophages and inhibition of necrosis
72
. IL2 is a type I cytokine, mainly produced by 
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CD4+ T cells after activation with specific antigens. IL2 mainly signals to T cells, B-cells and 
NK cells, where it leads to cellular growth, differentiation, survival, and activation induced 
cell death
73
. 
The production of cytokines from T cells is important in the control of mycobacterial 
infection, and a combination of cytokines can act together to produce a stronger immune 
response. Multifunctional T cells, T cells producing several cytokines, have been implicated 
to have an important role in mycobacterial protection. It has been seen that the presence of a 
large number of multifunctional TH1-cells (producing IFNγ, TNFα, and IL2) in the lung 
correlates with a reduced burden of mycobacteria
74
. In murine macrophages infected with M. 
avium, IFNγ stimulation alone was not enough to induce a strong bactericidal response, but 
inducing TNFα as a second signal gave acidification of the mycobacterial-containing 
phagosome and increased bacterial killing
75
.  
Many aspects regarding the host immune responses against infection with M. tuberculosis 
are well established, although much remains unclear. Much of the work carried out has been 
done in mice using different strains of M. tuberculosis, while less work has been carried out 
using the opportunistic pathogen M. avium. The oxidative stress sensor KEAP1 has been 
shown to be involved in regulation of inflammation and autophagy following M. avium 
infection, although the mechanism behind this regulation remains unclear. T cells 
undoubtedly have an important role in the host defence against mycobacteria, but the role of 
multifunctional T cells in M. avium infections in humans has not yet been established. If and 
how KEAP1 regulate antigen presentation and hence activation of the adaptive immune 
system is neither known.    
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2 Aims and objectives  
 
M. avium infection induces an inflammatory response in primary human macrophages. 
KEAP1 appears to have a negative regulatory effect on this inflammatory response as 
knockdown of KEAP1 increases the inflammatory response following M. avium infection. 
The underlying mechanisms are not fully understood, neither are the consequences for 
shaping of the mycobacterium-specific adaptive immune response. The aims of this thesis are 
to investigate the mechanism in which KEAP1 regulate the inflammatory response in primary 
human macrophages following M. avium infection, and if KEAP1 affects antigen presentation 
and the following adaptive immune response.  
Specific aims include:  
1. Investigate if the mechanism by which KEAP1 regulates M. avium induced 
inflammation can be dissected using Human embryonic kidney (HEK) 293 cells as a 
model system. 
2. Investigate the role of the ubiquitination-associated KEAP1 interaction partners Cul3 
and Rbx1 in the regulation of inflammatory responses following M. avium infection in 
primary human macrophages. 
3. Investigate if KEAP1 modulates antigen-presentation in response to M. avium 
infection in primary human macrophages, and subsequently affects the adaptive 
mycobacteria-specific CD4+ T cell response. 
16 
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3 Materials and methods 
3.1 Isolation and seeding of peripheral blood mononuclear cells 
Peripheral blood mononuclear cells (PBMCs) isolated from buffy coats from healthy donors 
were used for all experiments with human cells. The buffy coats were obtained from the blood 
bank at St. Olavs hospital, and the use of PBMCs from healthy blood donors has been 
approved by the Regional Committee for Medical and Health Research Ethics at NTNU. 
Isolation was done by density gradient centrifugation, where buffy coat diluted in 100 ml 
Dulbecco’s phosphate buffered saline (PBS, Sigma-Aldrich) was layered on top of 
lymphoprep (Axis sheld) in 50ml falcon tubes. The tubes were spun down at 645 RCF for 20 
minutes without brakes and at 20°C. Lymphoprep has a density of 1.077 g/ml, which allows 
for the isolation of mononuclear cells which have a lower density. The mononuclear cells will 
be seen as a thin creamy layer on the interphase between the lymphoprep and the serum/PBS 
after centrifugation. Erythrocytes and granulocytes have a higher density and will pass 
through the solution and form a pellet at the bottom of the tube. The layer containing PBMCs 
was pipetted out and transferred to new tubes. No lymphoprep was transferred, as this is toxic 
to the cells. The cell suspension was then spun down again at 800 RCF for 10 minutes, now 
with brakes 7-7. The supernatant was removed by decanting, and the pellet resuspended in 
Hanks’ balanced salt solution (Sigma-Aldrich) preheated to 37°C. The cells were spun down 
again, now at 127 RCF for 8 minutes. This step was repeated four times, in order to remove 
platelets, and purify the PBMCs as much as possible. After the fourth wash the cells were 
resuspended in 5 ml of RPMI-1640 (RPMI) (Sigma-Aldrich) media supplemented with Hepes 
(Gibco, life technologies) and 2mM L-glutamine (Sigma-Aldrich), followed by counting 
using a Countess automated cell counter (Invitrogen). Before using the Countess to quantify 
the number of cells, 10µl of the cell suspension (diluted 100:1) was mixed with 10µl of trypan 
blue (Life science). Trypan blue is a stain that is excluded by live cells, while dead cells are 
stained blue. The number of live cells/ml was used for further calculations.  
3.1.1 Differentiation of monocytes to monocyte derived macrophages  
For generation of macrophages from monocytes, the isolated PBMCs were diluted to a 
concentration of 5x10
6
 cells/ml in RPMI with 5% human serum, and plated out in appropriate 
tissue culture plates (24 well or 96 well, Costar). Monocytes makes up approximately 10% of 
isolated PBMCs
76
, and ten times the intended final number was therefore added per well. The 
cells were left in the incubator at 37°C and 5% CO2 for 1 hour to allow monocytes to adhere 
to the bottom of the well. The wells were then washed at least three times with Hanks’ 
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preheated to 37°C, in order to remove any non-adherent cells. Following the last wash, the 
Hanks’ was replaced with RPMI media with 30% human serum. After washing, 
approximately 250 000 cells were estimated to be attached per well in a 24 well plate. Cells 
were incubated at 37°C and 5% CO2. The media was changed to RPMI with 10% human 
serum after 4-5 days of incubation, when the monocytes had differentiated into monocyte 
derived macrophages (MDM). From this point, the MDMs were ready to use for further 
experiments.  
3.1.2 Expansion of T cells 
In the PBMC suspension there will be both APCs and lymphocytes. In the expansion step, the 
fraction of T cells specific to antigens of interest is increased compared to non-specific cells. 
Expansion activates the rare population of T cells that specifically recognise particular 
antigens (heat-killed M. avium in this thesis) presented by APCs (contained in the PBMC 
culture). The APCs will ingest heat-killed M. avium and present antigens to mycobacterium-
specific T cells, which in turn will be activated. The activated specific T cells will proliferate, 
resulting in a higher fraction of specific T cells than what was present in the PBMCs after 
isolation. For the expansion of T cells, the PBMCs were diluted to a concentration of 3x10
6
 
cells/ml in RPMI media containing 10% human serum, and 0.5 ml of the cell suspension was 
added per well in a 24 well plate. For the purpose of the experiments carried out in this thesis, 
mycobacterium-specific T cells were desired. To achieve this, heat-killed M. avium at desired 
concentrations was added to the suspension. IL2 (RnD Biosystems), which is important for 
the growth and proliferation of T cells, was added on day 2 at a concentration of 20U/ml. 
After 7-10 days of expansion, cells were used for experiments.  
3.1.3 Restimulation of T cells 
After 7-10 days of T cell expansion with heat-killed M. avium, the cells were restimulated 
with autologous macrophages generated from the same donor at day 0. Before restimulation 
the T cells were pooled into a 15ml tube, diluted in Hanks’, and spun down at 528 RCF for 5 
minutes. The supernatant was removed and the cells resuspended in pre-heated (37°C) RPMI 
media with 10% human serum. Cells were counted using the Countess, and T cells were 
added to the macrophages with a ratio of 10:1 of T cells to the estimated macrophage number 
of 250 000 macrophages per well (24 well plate). Prior to T cell restimulation macrophages 
were infected with M. avium for 4 hours (Section 3.2.1). T cells were restimulated for the 
desired time (varies between experiments) and for the last 4 hours of the restimulation time, 
Protein Transport Inhibitor Cocktail (eBioscience) was added to the cells. The transport 
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inhibitor contains Brefeldin A and monensin, which inhibits the secretory/transport pathway 
and results in accumulation of secreted proteins in the endoplasmic reticulum and Golgi 
apparatus (as described in the manufacturers’ protocol). This accumulation later allows 
detection of intracellular cytokines, which would normally be secreted, using flow cytometry. 
As a positive control 1-2 wells with T cells were stimulated with a Cell Stimulation Cocktail 
(eBioscience) containing phorbol 12-myristate 13-acetate (PMA) and ionomycin. This 
cocktail activates the T cells to produce cytokines (as described in the manufacturers’ 
protocol). These samples gave an indication of T cells functionality, and the functionality of 
the protocol for the flow cytometry staining. The T cells were restimulated with the 
stimulation cocktail overnight or as long as the remaining T cells were co-cultured with 
macrophages.  
3.2 Cultivation and preparation of M. avium  
A transformant of the virulent Mycobacterium avium clone 104 containing firefly luciferase, 
as described elsewhere
77
, was used in this thesis.  
The bacteria stock was stored in freezing media (bacterial suspension in 21% glycerol) 
at -80°C. To start a new culture, bacteria were thawed and 250µl of the stock suspension was 
added to 7ml of Middlebrook 7H9 complete media (Difco/Becton Dickinson) supplemented 
with glycerol, Tween 80, and albumin dextrose catalase. This media is commonly used for the 
cultivation of mycobacteria, and contains all nutrients needed for its growth. The culture was 
incubated on a shaker at 37°C for 3-6 days. The optical density (OD) for cultures used for 
experiments was between 0.3 and 0.6.  
3.2.1 Infection  
Bacterial culture for infection was prepared as described above. At the day of infection, the 
OD was measured using a spectrophotometer (Genesys 20, Thermo scientific) using a 
wavelength of 600nm. 1 ml of bacterial suspension was added to Eppendorf tubes, which was 
centrifuged at 9300 RCF for 2 minutes. The bacterial growth media containing Tween, which 
is toxic to human cells, was removed and the pellet was resuspended in 1 ml PBS. Sonication 
and vortexing was carried out to create a single cell suspension. Due to bacterial loss in the 
previous step, the OD was measured again. Knowing that OD 1=4.5x10
8
 cells/ml (calculated 
from serial dilutions and colony forming unit (CFU) counts) the number of CFUs per ml can 
be calculated from the OD measured. The CFU count is confirmed by plating the suspension 
on Middlebrook 7H10 agar (Becton Dickinson GmbH) at increasing dilutions, and the 
colonies were counted after approximately one week incubation at 37°C and 5% CO2. Before 
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infection, the medium of the cells to be infected was changed, followed by addition of the 
bacterial suspension at the desired multiplicities of infection (MOI). After 4 hours of 
infection, the media containing bacteria were removed, and cells were harvested for analysis 
or used further in experiments.  
3.2.2 Heat-killing 
For heat-killing of M. avium, a culture was prepared as explained above.  
Heat-killing of bacteria was done by incubating the bacterial suspension on a heat block 
(QBH2, Grant). To find optimal conditions to heat-kill bacteria, different temperatures and 
times were tested, followed by CFU counts and confocal microscopy. For this purpose M. 
avium dsRed (made in our lab) was used to allow visualisation of the bacteria in confocal 
microscopy. After treatment the bacteria were plated on 7H10 agar and examined by confocal 
microscopy to investigate the viability. The treatments tested were: 90°C for 30 minutes, 
95°C for 20 or 30 minutes, and 72°C for 24 hours. The bacterial fluorescence was only visible 
in the bacteria subjected to 72°C for 24 hours. The bacteria were killed both at 72°C for 24 
hours and 95°C for 30 minutes (data not shown). For the purpose of this thesis, 95°C for 30 
minutes was used. After killing, the bacterial suspension can be stored at -20°C until needed.   
3.3 Human embryonic kidney 293 (HEK293) cells 
The HEK293 cells were cultured in Dulbecco’s modified eagles medium (DMEM) 
(BioWhittaker) supplemented with 10% fetal calf serum (FCS) (Invitrogen) and 2nM L-
glutamine. The cells were cultured in the presence of antibiotics, however, no antibiotics were 
present during experimental conditions. Two different HEK293 cell lines were used in this 
thesis: HEK293T (Thermo Scientific Open Biosystems) containing a T antigen and HEK293 
TLR2-GFP cells (kindly provided by Nadra Nilsen) stably transfected with TLR2 tagged with 
green fluorescent protein (GFP). HEK293T was cultured in DMEM containing the antibiotic 
penicillin streptomycin (PenStrep) (Sigma-Aldrich) and the HEK293 TLR2-GFP cells in 
DMEM containing Geneticin (G418) (Gibco, Life technologies).  
3.3.1 Thawing of HEK293 cells 
The cell stock is stored in liquid nitrogen in freezing media, consisting of DMEM with 30% 
FCS and 10% dimethyl sulfoxide (DMSO) (Sigma-Aldrich). Before thawing the cells, all 
reagents needed were heated to 37°C. The cells were transferred to a 50ml tube containing 
10ml preheated DMEM as soon as they were thawed, as DMSO is toxic to the cells. The cell 
suspension was centrifuged at 528 RCF for 5 minutes. The supernatant was removed by 
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decanting and the cells resuspended in 5ml preheated DMEM by careful pipetting. The cells 
were then transferred to at T25 tissue flask, and incubated at 37°C and 8% CO2.  
3.3.2 Maintenance and seeding of HEK293 cells 
In order to split HEK293 cells, the adherent monolayer of cells was washed with preheated 
PBS before trypsin-ethylenediaminetetraacetic acid (TE) (Gibco) was added for 
approximately 2 minutes to detach the cells from the flask. The cell suspension was moved to 
a 50ml tube and the flask flushed with PBS again. The suspension was centrifuged at 528 
RCF for 5 minutes, the supernatant removed, and cells resuspended in a small amount of 
DMEM. To avoid clumping, the tube was flicked gently and the cell suspension pipetted up 
and down. Cells were counted using the Countess automated cell counter, as previously 
described (Section 3.1). For further culturing, approximately 10ml DMEM (with appropriate 
antibiotics) containing 1x10
5
 cells/ml were seeded out in a T75 tissue flask.  Cells were 
incubated at 37°C and 8% CO2. Splitting of the cell stock was carried out 2-3 times a week. 
For use in experiments the cells were resuspended in media without antibiotics following 
centrifugation, counted and seeded out in the appropriate concentration.  
3.4 Transfection of cells in vitro 
Cell transfection is a tool that can be used to investigate the role of proteins and genes within 
a cell through introducing foreign nucleic acids to the cells. Transfections can be either stable 
or transient, depending on the material introduced to the cell. In stable transfections the 
genetic material is incorporated into the cells own DNA and is present also after the cell 
divides. Transiently transfected cells do not incorporate the nucleic acids into their genome, 
and are only functional for a limited period of time
78
. 
There are several ways cells can be transfected. These can broadly be categorised into 
biological, chemical, and physical methods. Biological methods include virus transfection, 
where a virus is used to introduce the foreign genetic material into the cell. Physical methods 
include microinjections, biolistic particle delivery, electroporation, and laserbased 
transfection. These methods involve the direct insertion of nucleic acids into the cell or 
disturbance of the cell membrane that allows nucleic acids to pass. The principle of chemical 
transfection is that positively charged chemicals bind to DNA, and this positively charged 
complex is attracted to the negative cell membrane and taken up in an unknown fashion
78
. 
Chemical transfection was used throughout this thesis.  
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3.4.1 RNA interference 
RNA interference (RNAi) is a gene silencing pathway which is triggered by double stranded 
RNA (dsRNA), and the interference occurs post transcription of messenger RNA (mRNA). 
Small interfering RNA (siRNA) is one type of dsRNA that causes post transcriptional gene 
silencing. Mature mRNA is exported from the nucleus to the plasma membrane, where the 
siRNAs have their effects. The principle of siRNA is shown in Figure 3.1. The siRNAs are 
derived from longer double stranded RNAs (dsRNAs) which can either be produced by the 
cell itself, or be introduced experimentally. dsRNA binds to the endonuclease enzyme Dicer, 
which cuts the siRNA into short fragments, approximately 21 nucleotides long. These short 
fragments then bind to the effector complex RNA-induced silencing complex (RISC). Here 
one strand is chosen as a guide strand, which continues to be bound to the complex, while the 
other strand is degraded. The guide strand directs RISC to complementary regions on target 
mRNA through Watson-Crick base pairing. Once bound the RISK complex catalyses 
cleavage of the mRNA by the RNaseH enzyme Argonaute (Slicer), degrading it. The 
degradation of mRNA before it is translated leads to reduced or depleted expression of the 
mature protein in the cell
79
.  
 
Figure 3.1: The principle of siRNA silencing  Long dsRNA is introduced to the cell, and cleaved 
into shorter siRNAs by the enzyme Dicer. Alternatively the siRNA can be directly introduced to the 
cell. The siRNA then assembles with the RISC complex, where one strand (sense strand) is cleaved by 
argonaute (AGO2)/Slicer, while the guide strand (antisense) stays associated with the complex. The 
antisense strand is used to target out complementary mRNA, which is then cleaved. The RISC 
complex can be recycled, and target more mRNA
80
.   
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3.4.1.1 siRNA transfection in vitro 
Transient transfection of synthetically produced siRNAs (Qiagen) was used for altering of 
gene expression in cells throughout this thesis. The siRNA was chemically delivered via 
lipofection by the use of siLentFect lipid (Bio Rad), which is a proprietary mix of cationic 
compound and a co-lipid developed for the delivery of siRNA to mammalian cells in culture 
(as described in the manufacturers’ protocol). Transfection of siRNA targeting KEAP1, Cul3, 
and Rbx1 were all carried out using siLentFect. The siRNA for any specific gene used was a 
pool of 4 different siRNAs specific for the same transcript (for details see Appendix 1).  
AllStar (AS) negative control (Qiagen) was used as a non-targeting negative control for the 
siRNA. Analysis of the effect of the treatment was done using real-time quantitative PCR 
(Section 3.5).  
3.4.1.2  siRNA treatment of human monocyte derived macrophages 
For siRNA knockdown in human primary macrophages, cells were seeded and differentiated 
as described in Section 3.1.1. After 5-7 days in culture, the media was changed to RPMI with 
10% human serum, and the cells were transfected. Optimization of siRNA treatment of human 
primary macrophages has previously been carried out in our lab, and has shown that the best 
knockdown is seen after two treatments, at 0 hours and 48 hours, followed by further 
experiments at 72 hours. 0 hours is defined as the time where the treatment is started. Two 
solutions were prepared with OptiMem (Gibco, Life technologies) (50µl per well in a 24 well 
plate) plus either siLentFect (1.5µl per well in a 24 well plate) or siRNA (20nM). The two 
solutions were then mixed together through careful pipetting. The solution was left to 
incubate at room temperature for 15-20 minutes allowing siLentFect to form a lipid 
membrane around the siRNA. Following incubation, the solution was added to the cells, 
taking care to spread it evenly.  
3.4.1.3  Optimisation of siRNA treatment of HEK293 cells 
Different cell types differ in their response to various treatments, and protocols should be 
optimised to each cell type. An optimisation for siRNA treatment of the HEK293 cells was 
therefore carried out. HEK293 TLR2-GFP cells were prepared as described in Section 3.3.2, 
and left overnight. siRNA targeting KEAP1 was prepared as described in Section 3.4.1.2. 
Cells were either transfected 1 time and left for 48 hours in transfection media, or treated 2 
times at 0 hours and 48 hours (as the primary human macrophages), and knockdown was 
measured after 72 hours. This experiment showed that the knockdown effect was high (more 
than 90% less expression of the mRNA of interest) already after 1 treatment and 48 hours, and 
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2 treatments did not increase the knockdown efficiency (Figure 3.2 A). For some 
experiments, the HEK293 cells were used for further transfections, and we therefore wanted 
to investigate the persistence of the knockdown effect after changing the medium containing 
siRNA. Cells were prepared as described above, and treated with siRNA (non-targeting (AS) 
or KEAP1) one time. The media was either changed after 24 hours, or left unchanged. This 
showed that the knockdown of KEAP1 in the cells where the media was changed after 24 
hours was as good as in the cells left in siRNA containing media (Figure 3.2 B). This 
suggests that the media can be changed 24 hours after siRNA treatment, and the knockdown 
effect will persist for at least 96 hours from the start of the treatment. The mRNA levels were 
measured using real-time PCR.  
A)                                                        B) 
             
Figure 3.2: Establishment of siRNA treatment of HEK293 cells.  A) Shows the knockdown effect 
of KEAP1 compared to non-targeting control (AS) in HEK293 TLR2-GFP cells, after 1 siRNA 
treatment and 48 hours in siRNA media, and 2 treatments after 0 and 48 hours and 72 hours of siRNA 
treatment. B) Shows the persistence of the knockdown effect of KEAP1 after 1 treatment in HEK293 
TLR2-GFP cells. Comparing cells left in the siRNA containing media with cells where the media was 
changed after 24 hours of siRNA treatment. mRNA levels measured using real-time PCR, and 
normalised to GAPDH (see Section 3.5). Data in A) collected from one experiment in duplicates, and 
B) from one experiment and single wells. 
3.4.2 Transfection of plasmids into HEK293 cells in vitro 
To obtain expression of specific genes HEK293 cells were transfected with plasmids 
containing the genes of interest. For this transfection, GeneJuice Transfection reagent 
(Novagen) was used. This reagent is composed of nontoxic cellular proteins and a small 
amount of a novel polyamine (as described in the manufacturers’ protocol). 
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3.4.2.1 Transfection of CD14 and pcDNA-cherry 
The GeneJuice transfection method was used to introduce plasmids containing pcDNA-
CD14
81,82
 or pcDNA-cherry. The protocol for GeneJuice transfection for a 24 well plate is 
described below. 
1. The day before transfection, cells were seeded out at a concentration of approximately 
150 000 cells/ml and 0.5ml was added per well. Cells that had previously been siRNA 
treated were also used. The cells should be approximately 50% confluent when 
transfected. Cells were left to incubate at 37°C and 8% CO2.  
2. For each well to be transfected, 25µl of serum free media (DMEM) and 3µl GeneJuice 
per 1µg DNA was mixed in a sterile tube. The solution was mixed thoroughly by 
vortexing.  
3. The solution was incubated at room temperature for 5 minutes.  
4. The desired concentration of plasmid per well was added to the above mixture and 
mixed by careful pipetting and incubated for 10-15 minutes at room temperature.  
5. 25µl of the mixture was added per well, in droplets. The plate was rocked to ensure an 
even distribution.  
6. The plates were incubated for 24-72 hours at 37°C and 8% CO2. 
7. Cells were now ready for stimulation and harvesting for analysis.  
For pcDNA-CD14 and pcDNA-cherry, 0.15µg of the plasmid was added per well. 
3.4.2.2  ELAM-Luciferase and IFNβ-Luciferase assay 
We wanted to investigate the activation of NF-κB and transcription of IFNβ in HEK293 cells 
following stimulation. For this purpose we used a luciferase assay, where cells were 
transfected with plasmids containing the gene of interest and a reporter gene. ELAM-
luciferase assay (Promega) was used as a reporter for NF-κB activation, and contains the 
promoter of Endothelial Leucocyte Adhesion Molecule-1 (ELAM) containing a NF-κB site, 
fused with the firefly luciferase gene. Upon NF-κB activation luciferase enzyme is produced, 
which can then be detected by adding luciferase substrate and measure fluorescence. The 
IFNβ reporter plasmid (provided by John Hiscott, McGill University, Montreal, Canada) 
functions in a similar fashion when IFNβ is produced. Cells were also transfected with 
TLR2
81,82
, as HEK293 cells do not express this TLR. In order to see whether any activation 
was due to TLR2 stimulation, some cells were transfected with an empty control plasmid 
(pcDNA3, Invitrogen). These cells should show low activation compared to cells transfected 
with TLR2. The experimental procedure for a 96 well plate is described below. In addition to 
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the plasmids mentioned above, all cells were transfected with a plasmid containing Renilla 
luciferase (Promega). This was used as a constitutively active control and to measure the 
transfection efficiency and cell numbers.  
1. On day 1, cells were seeded out at a concentration of approximately 1x105 cells/ml 
(100µl/well) 
2. When cells were approximately 50% confluent (1-2 days) the cells were transiently 
transfected using GeneJuice. The following was added per well:  
 50ng ELAM-luc/IFNβ-luc  
 1ng Renilla luc, 
 10ng TLR2 plasmid 
3. The plasmids were diluted in 10µl DMEM (with no additions) per well, and Gene 
Juice was added to a final concentration of 3µl/µg DNA.  
4. The mixture was incubated for 5-15 minutes at room temperature, and 10µl was added 
per well. The cells were incubated until confluent (12-48 hours). 
5. On the day of stimulation, the media was carefully removed and 90µl fresh media was 
added. Cells were stimulated with either M. avium at a MOI of 10:1, Lipomannan 
(LM) at 100ng/ml or 500ng/ml, or lipopolysaccharide (LPS) at 50ng/ml for 4 hours in 
a total of 10µl/well. 
6. After stimulation, the supernatant was removed and frozen down at -80°C. The cells 
were then lysed using passive lysis buffer (50µl/well) (Promega), and incubated at       
-20°C overnight for improved lysis. 
7. Cells were defrosted to room temperature for at least 2 hours for best lysis. Luciferase 
substrate (-20°C) and Renilla substrate (colentracine -20°C) were also defrosted to 
room temperature.  
8. 15µl per sample lysate was added to two separate optiplates. 35µl luciferase substrate 
was added per well to 1 plate and luciferase fluorescence was measured by Victor 3 
luminometer (PerkinElmer). There should be no more than 5 minutes from addition of 
luciferase substrate until fluorescence measurement. 35µl Renilla luciferase substrate 
was added per well to the other plate and measured in the same manner.  
3.5 Real-time quantitative polymerase chain reaction  
In order to investigate the efficiency of siRNA treatment and expression of genes of interest, 
real-time quantitative polymerase chain reaction (real-time PCR) was used. This is a method 
that allows for quantification of nucleic acids in a sample. DNA templates are replicated 
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exponentially, giving a relative relationship between the amount of starting target sequence 
and the amount of PCR product produced per cycle. For the purpose of this thesis, the real-
time quantitative TaqMan assay (Life technologies) was used. Thermus aquaticus (Taq) is a 
DNA polymerase with 5’ to 3’ exonuclease activity. The TaqMan probe has a fluorescent 
reporter dye on its 5’ end and a quencher dye on the 3’ end (Figure 3.3). As long as the 
TaqMan probe is intact, the fluorescent reporter and the quencher are in close proximity. This 
inhibits any fluorescence emitted from the reporter to be detected, as any fluorescence emitted 
is absorbed by the quencher, following the fluorescence resonance energy transfer (FRET) 
principle. When a target sequence is present, the specific primer binds to the sequence, which 
has a TaqMan probe downstream of the primer binding site. The TaqMan probe is cleaved by 
the 5’ nuclease activity of the Taq polymerase, which allows the reporter flurophore to move 
away from the quencher, and a fluorescent signal can be detected. For each cycle of the PCR 
reaction more reporter substrate is cleaved from the probes and the fluorescent signal is 
therefore proportional to the amount of target sequence in the sample
83
.  
 
 
Figure 3.3: The principle of real-time PCR TaqMan assay.  When the TaqMan probe is intact no 
fluorescence is emitted due to the receptor flurophore and the quencher being in close proximity. 
When the target sequence is present, a primer binds and transcribes the strand. The TaqMan probe is 
cleaved, and the flurophore emits a signal
83
. 
3.5.1 RNA extraction and cDNA synthesis 
Cells for real-time PCR analysis were lysed and harvested using 350µl buffer RLT (Qiagen) 
containing 0.1% β-mercaptoethanol (Sigma-Aldrich). β-mercaptoethanol was added to 
inactivate RNases in the lysate. The lysate was then added to 2ml sample tubes RB (Qiagen), 
and frozen down at -80°C until RNA isolation. RNA isolation was carried out using RNeasy 
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mini kit and QIAcube (Qiagen) including DNase, following the manufacturers’ protocol. 
350µl cell lysate gives RNA suspended in 50µl water after isolation. The RNA concentration 
was measured using NanoDrop1000 spectrophotometer (Thermoscience) at 260nm. The RNA 
was then used to produce complementary DNA (cDNA) using High Capacity RNA-to-cDNA 
Kit (Applied Bioscience). This is a reverse transcription kit which gives high performance 
with the TaqMan gene expression master mix, among other PCR enzymes. The kit contains 
an RT buffer mix (2x) and an RT enzyme mix (20x), and is optimised for a 20µl reaction. For 
every reaction 1µl RT enzyme mix, 10µl RT buffer mix, and 9µl of the previously isolated 
RNA was mixed. The reaction is incubated as described in Table 3.1 using a thermal cycler 
(BioRad).  
Table 3.1: Temperatures and times for cDNA synthesis incubation 
°C Time (minutes) 
37 60 
95 5 
4 Forever 
 
The 37°C incubation is the step at which reverse transcription occurs, and the reaction is 
stopped when heated to 95°C. The cDNA can then be stored at 4°C until further use. The 
remaining RNA can be stored at -80°C for further use. 
3.5.2 Real-time PCR procedure 
Real-time PCR was carried out subsequent to cDNA synthesis, for investigation of the 
expression of genes of interest at the mRNA level. The total volume per real-time PCR 
reaction should be 20µl and consist of 1-9µl of the sample, 10µl TaqMan Universal 
Mastermix (Life technologies), 1µl TaqMan Gene Expression Assay mix (contains two 
primers and a probe) (Life technologies), and water. We aimed to have a concentration of 9-
10ng cDNA per reaction although lower concentrations were also used with successful 
results. Water was added to the cDNA samples to dilute them to a final concentration of 
between 1 and 10ng/µl. 1-9µl of the diluted sample was then added to each reaction tube 
depending on the cDNA concentration. A final volume of 20µl was reached by addition of 
water. For convenience, the total amounts of master mix, assay mix, and water needed per 
target were first mixed together in a 1.5ml Eppendorf tube, and then allocated to the reaction 
tubes. The master mix is glycerol based, while the assay mix is water based, therefore the 
reaction mix was pipetted up and down 5-10 times to ensure proper mixing. MicroAmp 
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Optical 96-well reaction plates (Applied biosystems) were used for the real-time PCR run. 
The premixed reaction mix was added to the appropriate wells of the 96 well plate and the 
samples were then added directly to the plate. The plate was sealed with optical adhesive 
cover, and centrifuged at 528 RCF for 2 minutes. StepOnePlus (Applied Biosystems) real-
time PCR system was used for the PCR run. The location of targets and samples on the plate 
was specified on the software, and the reaction cycle set as shown in Table 3.2. 
Table 3.2: The reaction cycle for real-time PCR using TaqMan probes 
Degrees Time (Sec)  
50 120 Hold Stage 
95 20  
95 1 Cycling stage (40 cycles) 
60 20  
  
The cycling stage is where the PCR reaction occurs. In the cycling stage the 95°C step 
denatures the cDNA, and the 60°C step allows for the Taq polymerase to anneal and 
transcribe its target sequence.  
3.5.3 Real-time PCR analysis 
From the real-time PCR run we get a threshold cycle (Ct) value, which is defined as the 
number of cycles required for the fluorescence to be greater than the minimal detection level. 
The detection level is set by the computer, but can be changed manually if needed. Relative 
quantification (RQ) or 2
-∆∆Ct
 was used in our analysis, which gives the expression level of a 
specific gene relative to a reference gene. The ∆∆Ct is equal to (∆Ct sample)-(∆Ct reference), 
and the ∆Ct values were derived from the Ct value of the reference subtracted from the Ct of 
the sample
83
. In our experiments, the glycolipid enzyme glyceraldehyde-3-phosphate 
dehydrogenase (GAPDH) was used as the reference gene. All samples are normalised to the 
reference gene to allow to correct for variations such as different amounts or quality of the 
starting mRNA, as well as different efficiencies in the PCR amplification
83
.   
3.6 Flow cytometry 
Flow cytometry is a method that is widely used both within research and diagnostics. It 
provides advantages such as analysis of cell populations on a cell to cell basis, rapid analysis, 
and it is able to measure several parameters of one single cell simultaneously. There are three 
main systems in flow cytometry; the fluidics, the optics, and the electronics. In addition to 
this, a computer is directly connected to the flow cytometer to allow for specific settings, as 
well as data analysis and storage. The fluidics system orders samples into a stream of single 
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cells, which can then be detected individually. The sample is injected in a narrowing central 
core, which is surrounded by sheath fluid. The sheath fluid moves faster than the sample, and 
creates a drag effect on the sample. This creates a velocity change in the fluid in the central 
core, where the velocity is higher in the centre, and 0 on the sides. This principle is called 
hydrodynamic focusing, and creates the flow of single cells. The single stream of cells does 
not mix with the sheath fluid under optimal conditions (laminar flow). This flow of single 
cells is passed through several beams of light, and is detected by specific channels when it has 
passed through the cell. Forward scattered light is detected by the forward scatter channel 
(FSC) and says something about the size of the cell. Side scatter is measured at approximately 
a 90° angle to the excitation line and is detected by the side scatter channel (SSC). This 
parameter tells about the granularity of the cell. Monoclonal antibodies can be tagged with 
fluorescent dyes, which allow for detection of specific cell properties. These fluorescent dyes 
(fluorochromes) are excited by a specific wavelength and emit light at a different specific 
wavelength. The emitted light is detected by different fluorescence (FL-) channels, and the 
data is sent to a computer for further analysis
84
. Figure 3.4 gives an overview of a flow 
cytometry setup.  
 
Figure 3.4: Schematic overview of a flow cytometry setup.  Beams of light (from a laser) are passed 
through a lens, and through the stream of single cells. Emitted light is detected by the FSC, SSC, or 
different photomultiplier tubes (PMTs). Optical filters and mirrors ensure that only certain 
wavelengths are passed through different filters. The combination of lasers, filters, and detectors 
allows for the detection of a combination of fluorochromes in a single cell. The collected data is lastly 
sent to a computer for further analysis
84
. 
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When several fluorochromes are used in the same experiment, there might be some 
spectral overlap, or “spill-over” where one fluorochrome will contribute to a signal on several 
detectors. By choosing fluorochromes that emit light at opposite sides of the spectrum one can 
avoid this, but this is often not possible when several fluorochromes are used. To correct for 
the spectral overlap, compensation is carried out. Here, the signal in detectors not assigned to 
the specific fluorochrome is subtracted from the total signal in that detector
85
. Compensation 
beads (BD bioscience) stained with the fluorescent antibodies were used to carry out 
compensation in the experiments presented in this thesis.  
Flow cytometry was used for analysis of T cell activation and for investigation of 
surface marker changes on macrophages in this thesis. The analysis was done using the LSRII 
(BD) flow cytometer.  
3.6.1 Staining of T cells for flow cytometry 
Following T cell expansion and restimulation, as described in Section 3.1, cells were stained 
and fixed for flow cytometry analysis. T cells were stained extracellularly using antibodies 
specific for the surface proteins CD3, CD4 and CD8, to allow recognition of the cells of 
interest, before fixation using 2-4% paraformaldehyde (PFA) (VWR). Following fixation, the 
cells were permeabilised using 0.5% saponin (Sigma-Aldrich). The permeabilisation is done 
to allow intracellular staining of T cell effector cytokines, which accumulate within the T cells 
due to the addition of the transport inhibitor for the last 4 hours of the stimulation time. The 
cytokines investigated in this thesis were IFNγ, TNFα, and IL2. Table 3.3 gives an overview 
of the flurochromes used for extra- and intracellular staining of T cells. For a detailed staining 
protocol with extra- and intracellular markers see Appendix 2.  
Table 3.3: Overview of flurochromes used for T cell staining for flow cytometry 
Antibody Flurochrome Laser Filter Brand 
CD3 FIT-C 488 525/50 eBioscience 
CD4 Alexa 700 633 710/50 eBioscience 
CD8 BV 605 405 610/20 BioLegend 
IFNγ APC 633 670/14 eBioscience 
TNFα eFluor 450 405 450/50 eBioscience 
IL2 PE 561 780/60 eBioscience 
 
After staining, the cells were analysed using the LSR II flow cytometer.  
32 
 
3.6.2 Staining of macrophages for flow cytometry 
Flow cytometry was also used to investigate macrophages. The adherent macrophages were 
dislodged using a cell scraper in 24 well plates, or a non-enzymatic Cell dissociation solution 
(Sigma-Aldrich) in 96 well plates. When using the dissociation solution, the media was first 
removed, and cells washed with preheated Hank’s balanced salt solution. 100µl of the 
solution was then added per well, and the plate was incubated at room temperature for 15-20 
minutes for cells to dislodge. There was some trouble in dislodging the primary human 
macrophages using this solution, and pipetting up and down around the well was also 
required. Once cells were dislodged, extracellular staining was carried out using the same 
protocol as for extracellular staining of T cells (see Appendix 2). In addition to the 
extracellular staining, a viability stain (eBioscience) was used for the macrophages. This is an 
exclusion dye, where dead cells are stained because they have damaged membranes, while 
live cells exclude the dye and will not be stained. After step 4 (Appendix 2), the samples 
were washed twice with PBS (no FCS) by centrifugation, and 0.5µl viability stain diluted in 
500µl PBS was added to each sample. The samples were incubated for 30 minutes on ice, 
protected from light. After this, the rest of the steps for extracellular staining were carried out. 
Table 3.4 gives an overview of the antibodies and flurochromes used for investigation of 
macrophages.  
Table 3.4: Overview of flurochromes used for macrophage staining for flow cytometry 
Antibody Flurochrome Laser Filter Brand 
CD14 eFluor450 405 450/50 eBioscience 
CD11b perCP eFluor710 561 710/50 eBioscience 
HLA-DR APC 633 670/14 eBioscience 
CD80 PE 561 780/60 Immunotech 
 Viability stain 639 780/60 eBioscience 
 
3.6.3 Flow cytometric analysis of M. avium specific T cell activation 
Multicolour flow cytometry was used to investigate the cytokine response in T cells following 
expansion and restimulation with M. avium infected autologous macrophages. The following 
gating procedure was used to identify the T cells and their cytokine production 
1. Lymphocytes were identified by using the FSC and SSC. 
2. T cells were identified and gated by their CD3 positive staining.  
3. From the CD3 positive population, cells positively stained for CD4 were gated. 
4. From the CD3+CD4+ population, each cytokine (TNFα, IFNγ, and IL2) was assessed 
individually.  
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3.6.4 Flow cytometric surface marker characterisation on 
macrophages following KEAP1 knockdown 
Multicolour flow cytometry was used to assess activation marker changes following KEAP1 
knockdown in primary human macrophages. The following gating procedure was used to 
identify the macrophages and their surface marker expression: 
1. Macrophages were identified by CD14 and CD11b positive expression.  
2. Viable cells were identified by no staining with the viability stain. 
3. Viable CD14+CD11b+ cells were assessed for HLA-DR and CD80 expression, two 
molecules that are involved in antigen presentation and T cell activation.  
3.6.5 Processing of flow cytometry data 
For analysis of flow cytometry data, FlowJo X was used. Microsoft Excel 2010 and GraphPad 
Prism were used for further processing of the data and for graphical display. For statistical 
analysis unpaired Student’s T-test was used. 
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4 Results 
4.1 Testing HEK293 cells as a model system for investigating the 
mechanisms behind how KEAP1 regulate inflammatory responses 
Recent results from our group indicate that KEAP1 supresses the inflammatory response in 
primary human macrophages following infection with M. avium
55
. The mechanism behind 
this regulation is still unknown. As KEAP1 has many interaction partners, including the 
Cul3/Rbx1 E3 ubiquitin ligase complex, the selective autophagy receptor p62, the 
inflammatory signalling protein IKKβ, and the transcription factor NRF2, a whole variety of 
mechanisms may be influenced by KEAP1. One of the aims of this thesis was therefore to 
investigate the role of Cul3 and Rbx1 in the regulation of M. avium induced inflammatory 
responses. HEK293 cells were chosen as a starting point for these experiments as HEK293 
cells are known to be easy to transfect, and due to no donor variations it is easier to obtain 
reproducible results compared with the use of primary human cells. Because of these 
advantages, we wanted to investigate whether or not the HEK293 cell line was suitable as a 
model system for dissecting the role of KEAP1 in regulating inflammatory responses in 
mycobacterial infection. 
4.1.1 KEAP1 knockdown decreases the TNFα production in HEK293 
TLR2-GFP cells following M. avium infection 
TLR2 is one of the TLRs that have been shown to recognise mycobacterial antigens
19-21
. 
HEK293 cells do not express TLR2, and we therefore used HEK293 cells stably transfected 
with TLR2 and GFP. We first confirmed that TLR2 was present in the cell using confocal 
microscopy to look for the GFP-tagged TLR2 protein. Figure 4.1 A shows that GFP was 
detected in confocal microscopy, and we can therefore assume that TLR2 was present in the 
HEK293 cells used in our experiments.  
HEK293 TLR2-GFP cells were treated with KEAP1 targeting siRNA (siKEAP1) or 
non-targeting siRNA (siAS) as described in Section 3.4.1.3, followed by a 4 hour infection 
with M. avium at a MOI of 10:1. The knockdown of KEAP1 was more than 90% as measured 
by real-time PCR (Figure 4.1 B). The transcription of TNFα 4 hours post infection with M. 
avium was also measured for siAS and siKEAP1 treated cells using real-time PCR (Figure 
4.1 C). The fold change in TNFα expression between infected and uninfected samples is 
shown in Figure 4.1 C. In contrast to what has been observed in primary human 
macrophages, M. avium induced TNFα production decreased when KEAP1 was knocked 
down in the HEK293 TLR2-GFP cells. High Ct values (above 30) were obtained, indicating 
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that the level of the target sequence was very low and the results may not be reliable (data not 
shown).  
Due to low TNFα expression in the HEK293 TLR2-GFP cells, we tried to additionally 
transfect the co-receptor CD14 into the cells (as described in Section 3.4.3.1) to investigate if 
this increased the response to M. avium infection. pcDNA-cherry was used as control for 
transfection efficiency and visualised using fluorescence microscopy (Figure 4.1 D). It was 
found that transfection was effective already 24 hours post addition of transfection reagents 
(Figure 4.1 D). For infection experiments, cells were transfected with CD14 or pcDNA-
cherry, 48 hours later the medium was changed and cells infected with M. avium at a MOI of 
10:1 for 4 hours. Comparing the TNFα mRNA levels for HEK293 TLR2-GFP cells with and 
without CD14 showed only minimal effect for the co-receptor expression on the TNFα 
response to M. avium in these cells (Figure 4.1 E). Also, in this experiment the Ct values 
obtained from real-time PCR were above 30, indicating that the level of the target sequence 
was low (data not shown). 
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D)      E) 
 
Figure 4.1: TNFα production by HEK293 TLR2-GFP cells decreases following KEAP1 
knockdown and M. avium infection  A) Confocal image confirming the presence of TLR2 tagged 
with GFP in stably transfected HEK293 cells. Scale bar represents 20µm (imaged in cooperation with 
Jane Awuh). B) The knockdown efficiency following KEAP1siRNA treatment of HEK293 TLR2-
GFP cells compared to the non-targeting siRNA control AS. C) The fold change in TNFα mRNA level 
measured by real-time PCR for HEK293 TLR2-GFP cells treated with non-targeting siRNA (AS) or 
KEAP1 siRNA after 4 hour infection with M. avium at a MOI of 10:1. D) Fluorescence microscopy 
image of HEK293 TLR2-GFP cells 24 hours post transfection with pcDNA-cherry, demonstrating that 
transfection was efficient. Scale bar represent 200µm (imaged in cooperation with Jane Awuh). E) The 
relative quantification of TNFα expression at the mRNA level in HEK 293 TLR2-GFP cells 
transfected with co-receptor CD14, and untransfected cells after a 4 hour infection with M. avium. 
Data collected from one experiment done in duplicates. 
4.1.2 M. avium-induced NF-κB activation decreases following KEAP1 
knockdown in HEK293 cells 
The TNFα induction following M. avium infection was found to be low in the HEK293 
TLR2-GFP cells. We therefore chose to test out a different method for measuring 
inflammatory activation, namely NF-κB activation. We also included a different HEK293 cell 
line (HEK293T), where TLR2 was transiently transfected in, as described in Section 3.4.2.2. 
HEK293T cells were transfected with either pcDNA+ELAM-luciferase+Renilla luciferase, or 
TLR2+ELAM-luciferase+Renilla luciferase. In addition, the HEK293 TLR2-GFP cells were 
transfected with pcDNA+ELAM-luciferase+Renilla luciferase to investigate the TLR2 
functionality. 48 hours after transfection, cells were stimulated for 4 hours with M. avium at a 
MOI of 10:1, lipomannan (LM, 100ng/ml), or lipopolysaccharides (LPS, 50ng/ml) (Figure 
4.2 A). LM is a glycolipid derived from the cell wall of Mycobacterium tuberculosis, and is a 
known TLR2 ligand
18
. LPS is a cell wall protein found on gram negative bacteria that is not a 
TLR2 ligand but is recognised by TLR4.  
As displayed in Figure 4.2 A, HEK293T cells transfected with an empty plasmid 
showed low NF-κB activation following all the stimulations, as demonstrated by low 
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luciferase activity. The HEK293T cells transiently transfected with TLR2 showed NF-κB 
activation as displayed by increased luciferase activity following M. avium stimulation. Little 
activation was seen with stimulation with LM and LPS compared to the unstimulated sample. 
The HEK293 TLR2-GFP cells showed activation at the same level as the HEK293T cells 
lacking TLR2, indicating that the TLR2 in the stably transfected cells was non-functional 
(Figure 4.2 A). 
As the stably transfected HEK293 TLR2-GFP cell line did not appear to get activated 
following stimulation, we chose to proceed with the HEK293T cells and transiently transfect 
these with TLR2 for the individual experiments. We next wanted investigate the activation of 
NF-κB following KEAP1 knockdown using the ELAM-luciferase assay. The HEK293T cells 
were given siRNA (KEAP1 or AS) treatment for 24 hours, followed by transient TLR2 
transfection for 48 hours. The KEAP1 knockdown efficiency was measured 72 hours post 
knockdown using real-time PCR, and was above 70% (Figure 4.2 B). Transiently TLR2 
transfected cells +/- KEAP1 knockdown were then stimulated as described above and the 
induction of inflammation was analysed by measuring luciferase activity as readout for NF-
κB activation (Figure 4.2 C). Due to low activation of NF-κB with LM at 100ng/ml (Figure 
4.2 A) we chose to increase the dose of LM to 500ng/ml. For all cells transfected with empty 
plasmid the NF-κB activation was relatively low, as would be expected (Figure 4.2 C). Both 
M. avium and LM appear to activate NF-κB, with LM giving the highest activation (Figure 
4.2 C). Activation following stimulation with LPS was no higher than the unstimulated 
sample, as expected. Comparable to the TNFα measurements with the stably transfected 
HEK293 TLR2-GFP cell line (Figure 4.1 C), KEAP1 knockdown led to decreased M. avium 
induced inflammation measured by NF-κB activation also in HEK293T cells transiently 
transfected with TLR2 (Figure 4.2 C). Similar results were seen with LM. We also 
investigated the IFNβ induction using IFNβ-luciferase with the same stimulations as above. 
We could not detect activation of the IFNβ-luciferase in this assay (data not shown).  
The results in Section 4.1 taken together indicate a decrease in M. avium-induced 
inflammatory response following KEAP1 knockdown in HEK293 cells. The findings from 
experiments using the HEK293 model system are in contrast to what has previously been seen 
in human primary macrophages. Due to these opposing results, we believe that the HEK293 
cell line is not suitable to use as a model system for our investigation. 
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A) 
 
B)         C) 
 
Figure 4.2: NF-κB activation following various stimulations decreases in HEK293 cells following 
KEAP1 knockdown  A) Shows the activation of NF-κB in HEK293T cells transiently transfected 
with TLR2, or HEK293 TLR2-GFP cells, in response to 4 hour stimulation with M. avium (MOI 
10:1), LM (100ng/ml) and LPS (50ng/ml). Activation was measured by the activity of ELAM-
luciferase, and normalised using Renilla luciferase. B) The knockdown efficiency in HEK293T cells 
after one siRNA treatment (KEAP or AS) for 24 hours, followed by TLR2 transfection for 48 hours. 
Knockdown measured at the mRNA level using real-time PCR. C) The NF-κB activation in HEK293T 
cells transfected with TLR2, in addition to ELAM-luciferase and Renilla luciferase. Cells were treated 
with either non-targeting siRNA (AS) or siRNA targeting KEAP1. Cells were stimulated for 4 hours 
with M. avium (MOI 10:1), LM (500ng/ml) and LPS (50ng/ml). NF-κB activation measured by the 
activity of ELAM-luciferase, normalised to Renilla luciferase. Data collected from one experiment in 
triplicates. 
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4.2 Cul3 and Rbx1 knockdown increases the inflammatory response 
to M. avium infection in primary human macrophages 
KEAP1 appears to suppress the inflammatory response following M. avium infections in 
primary human macrophages
55
. As the HEK293 cells did not give the same results as 
previously obtained in primary human macrophages, we continued our work in primary cells, 
for more reliable results to study the effect of Cul3 and Rbx1. Cul3 and Rbx1 are two of the 
proteins known to interact with KEAP1, and are both part of the E3 ubiquitin ligase complex 
associated with KEAP1. In order to increase our understanding of how the negative regulation 
of inflammation associated with KEAP1 occurs, we wanted to investigate the roles of Cul3 
and Rbxl. If it is the ubiquitination of proteins associated with KEAP1 that is important for its 
negative regulation of inflammation in M. avium infection, we expect the removal of Cul3 and 
Rbx1 to show increased inflammation, as we see for the removal of KEAP1.  
PBMCs were isolated, and monocytes differentiated to macrophages as described in Section 
3.1. siRNA treatment targeting KEAP1, Cul3, and Rbx1 was carried out as described in 
Section 3.4.1.2. After 72 hours of siRNA treatment, the cells were infected for 4 hours with 
M. avium at a MOI of 10:1. The knockdown of each of the proteins was measured using real-
time PCR, and was above 75% in all samples (data not shown). The different siRNAs seemed 
specific to their target as the expression of KEAP1, Cul3, and Rbx1 were only affected by the 
targeting siRNA and not by the siRNAs targeting the other partners of the complex (Figure 
4.3 A). The inflammatory response 4 hours after M. avium infection was measured by mRNA 
analysis for the cytokines IFNβ, IP10, and TNFα by real time PCR (Figure 4.3 B). Consistent 
with previous results in our group
55
, knocking down KEAP1 increased the inflammatory 
response following M. avium infection. The results also indicate that an increased 
inflammatory response is the case when knocking down Cul3 and Rbx1. The IFNβ and IP10 
responses were relatively low with less than a four-fold increase in expression following 
infection, compared to the TNFα response where the fold induction was more than 20 
following knockdown of each of the three proteins KEAP1, Cul3 and Rbx1. The trend of 
increased cytokine production was, however, the same for all cytokines. The data in Figure 
4.2 B is from two experiments. To further confirm these findings, one additional experiment 
was carried out to look at the effect on inflammation when knocking down the three proteins. 
This experiment showed the opposite result of our previous findings and is therefore shown 
separately in Figure 4.3 C. The knockdown cells had a lower induction of the cytokines 
TNFα, IFNβ, and IP10 following M. avium infection, compared to cells treated with the non-
targeting control (AS). The knockdown was more than 60% for all the proteins at the mRNA 
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level (data not shown). The last experiment was done in duplicates, and showed big variations 
in the cytokine expression between the samples within the same condition. This was 
especially true for the siAS and siKEAP1 treated cells.  
 
Figure 4.3: Increased inflammatory response following M. avium infection in KEAP1, Cul3, and 
Rbx1 depleted primary human macrophages  A) Specific and efficient knockdown of mRNA levels 
of KEAP1, Cul3, and Rbx1 in primary human macrophages as assayed by real-time PCR. AS is non-
targeting siRNA used as control. Example of results obtained from one experiment in single wells. 
B,C) Macrophages were treated with siRNA to KEAP1, Cul3, or Rbx1 as indicated on the X-axis prior 
to 4 hour infection with M. avium (MOI 10:1). Results are shown as fold induction of TNFα, IFNβ, 
and IP10 mRNA levels in infected macrophages relative to uninfected controls. Results in B) are an 
average of two independent experiments with single well per condition, whereas results in C) are from 
one experiment with duplicate wells. 
A
S
K
E
A
P
1
C
ul
3
R
bx
1
0
50
100
150
siKEAP
%
 m
R
N
A
 l
e
v
e
l
A
S
K
E
A
P
1
C
ul
3
R
bx
1
0
50
100
150
siCul3
A
S
K
E
A
P
1
C
ul
3
R
bx
1
0
50
100
150
siRbx1
si
A
S
si
K
E
A
P
1
si
C
ul
3
si
R
bx
1
0
20
40
60
80
TNF
m
R
N
A
 f
o
ld
 i
n
d
u
c
ti
o
n
si
A
S
si
K
E
A
P
1
si
C
ul
3
si
R
bx
1
0
1
2
3
4
IFN
si
A
S
si
K
E
A
P
1
si
C
ul
3
si
R
bx
1
0
2
4
6
IP10
si
A
S
si
K
E
A
P
1
si
C
ul
3
si
R
bx
1
0
200
400
600
TNF
m
R
N
A
 f
o
ld
 i
n
d
u
c
ti
o
n
si
A
S
si
K
E
A
P
1
si
C
ul
3
si
R
bx
1
0
10
20
30
40
50
IFN
si
A
S
si
K
E
A
P
1
si
C
ul
3
si
R
bx
1
0
5
10
15
20
IP10
A)
B)
C)
42 
 
4.3 KEAP1 knockdown downregulates the expression of macrophage 
surface proteins CD80 and CD86 
Results in our group have shown that decreasing the expression of KEAP1 in macrophages 
increases the inflammatory response and autophagy in response to M. avium infections
55
. 
Research suggests that both autophagy
39
 and NF-κB86 signalling are important factors in 
antigen-presentation. Knowing this we wanted to investigate if KEAP1 knockdown in human 
primary macrophages would affect the antigen-presenting capabilities of these cells. We 
therefore decided to investigate expression changes of the activation markers CD80 and HLA-
DR (MHC class II) on the surface of macrophages following KEAP1 knockdown and M. 
avium infection. CD80 and HLA-DR are both proteins important for T cell activation
59
. 
Macrophages were isolated, differentiated, and siRNA treated as previously described 
(Section 4.2). Cells were then infected for 4 hours with M. avium, followed by staining for 
flow cytometry as described in Section 3.6.2. Macrophages were positively identified by 
expression of CD14 and CD11b, and the mean fluorescence intensity for CD80 and HLA-DR 
fluorochromes were measured. Figure 4.4 A exemplifies the mean fluorescence intensity 
measurement for CD80 expression. The histogram shows a comparison of uninfected AS 
siRNA treated cells with KEAP1 siRNA treated cells as well as staining with an isotype 
control antibody. We decided to look at the relative expression of the surface proteins, using 
uninfected AS siRNA treated cells as 100%. The expression of both CD80 and HLA-DR was 
significantly decreased on the surface of uninfected macrophages compared to control cells 
(Figure 4.4 B) There was no significant difference between siAS uninfected and infected 
cells for either CD80 or HLA-DR, nor between siAS infected cells and siKEAP1 infected 
cells. For CD80 there was a significant decrease in expression between the siAS uninfected 
and siKEAP infected cells, a difference not seen for HLA-DR (Figure 4.4 B). KEAP1 
knockdown was measured using real-time PCR, and was above 60% in all experiments (data 
not shown). These results indicate that removal of KEAP1 in human primary macrophages 
decreases the expression of both CD80 and HLA-DR, which are both important for T cell 
activation, and the decrease is independent of M. avium infection.  
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A) 
 
B) 
 
Figure 4.4: Decreased expression of CD80 and HLA-DR on the surface of primary human 
macrophages following KEAP1 knockdown  The relative expression of CD80 and HLA-DR on the 
surface of primary human macrophages following KEAP1 knockdown and M. avium infection was 
analysed. Cells were infected for 4 hours with a MOI of 10:1. A) Uninfected primary human 
macrophages were treated with either AS or KEAP1 siRNA and stained for flow cytometry. 
Macrophages were identified by the expression of CD11b and CD14. An example of the fluorescence 
intensity measurement done to investigate the expression of CD80 on the surface of human primary 
macrophages following siKEAP or siAS treatment is shown. The black line represents isotype control, 
the red line represents siAS treated cells, and the blue line represents siKEAP1 treated cells. B) 
Summarizes results from 4 experiments analysing CD80 (left) and HLA-DR (right) expression on 
primary human macrophages +/- infection and +/- AS/KEAP1 siRNA. Mean fluorescence intensity of 
CD80 and HLA-DR expression was quantified from histograms (as shown in A). The bars represent % 
expression of CD80 and HLA-DR relative to uninfected cells treated with non-targeting siRNA (AS). 
Mean +/- SD of four experiments.*p<0.05 **p<0.01.  
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4.4 Establishment of conditions for mycobacteria-specific T cell 
expansion and restimulation with autologous macrophages 
Results presented in Section 4.3 suggest a downregulation of the proteins CD80 and HLA-DR 
on the surface of human primary macrophages as a consequence of KEAP1 knockdown and 
thus might impact antigen-presentation and subsequent T cell activation. We wanted to 
investigate the activation of T cells following stimulation with M. avium infected autologous 
macrophages, and if KEAP1 knockdown in the macrophage would change this specific 
activation. For biological relevance it is desirable to use human primary cells, hence we first 
needed to establish a system to study mycobacteria-specific T cell responses to autologous 
macrophages. The assay involved PBMC isolation, T cell expansion, macrophage 
differentiation, and co-culturing of T cells and macrophages, all with cells isolated from the 
same donor.   
4.4.1 Establishment of conditions for mycobacteria-specific in vitro T 
cell expansion  
Mycobacteria-specific effector T cell responses take time to develop. For our investigation we 
used PBMCs from BCG vaccinated healthy donors, meaning some T cells should be 
mycobacteria-specific, and can also react with antigens from M. tuberculosis and M. avium 
(Markus Haug, unpublished data). The fraction of specific T cells however, is very low in 
PBMCs from healthy donors. In order to increase this fraction, activation and expansion of 
the mycobacteria-specific T cell fraction is needed. This was done by cultivating PBMCs with 
heat killed M. avium as described in Section 3.1.2 for 7-10 days. In parallel, autologous 
macrophages were generated from monocytes as described in Section 3.1.1. Following the 
expansion, specific T cell responses were investigated by co-culturing the expanded T cells 
with the autologous macrophages infected with M. avium, as described in Section 3.1.3. 
We first tested out different concentrations (1:1 and 3:1) of heat killed M. avium with 
the T cells during the expansion step. After 7-10 days of T cell expansion autologous 
macrophages were infected for 4 hours with M. avium, and the expanded T cells were added 
and left for restimulation overnight. 
The activation of mycobacteria-specific CD4+ TH1-cells was analysed by measuring 
the production of the TH1 effector cytokines TNFα, IFNγ, and IL2 from CD4+ T cells using 
multicolour flow cytometry (Section 3.6). An example of the gating used to assay the 
cytokine responses in CD4+ T cells is shown in Figure 4.5 A, starting with identification of 
lymphocytes, followed by gating for CD4+ T cells through CD3+ cells and then CD4+ cells. 
45 
 
In the CD4+ population the production of each cytokine was assessed individually. Using this 
gating strategy, Figure 4.5 B demonstrates the CD4+ T cell production of the cytokines IFNγ, 
TNFα, and IL2 following stimulation with Cell Stimulation Cocktail overnight. The 
frequency of CD4+ T cells producing TNFα, IFNγ, and IL2 following restimulation with M. 
avium infected autologous macrophages is presented in Figure 4.5 C. The response for the 
CD4+ T cells expanded both 1:1 and 3:1 with heat-killed M. avium was low, with less than 
0.5% of CD4+ T cells producing either cytokine for all the conditions tested. However the 
response in the T cells expanded 3:1 was higher in the majority of the conditions tested. 
Higher concentrations of heat killed M. avium (5:1) in the expansion step was also tested, but 
it seemed that the T cells got activated already before restimulation as seen by cytokine 
production by the unstimulated cells (data not shown). Due to these findings we chose to 
continue with an expansion ratio of 3:1 from here. 
A)  
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B) 
 
C) 
 
Figure 4.5: Cytokine response in CD4+ T cells expanded under different conditions and 
restimulated through co-culturing with M. avium infected autologous macrophages.  PBMCs 
were isolated, and T cells were expanded with heat-killed M. avium at a ratio of 1:1 or 3:1 for 10 days 
and restimulated overnight with autologous macrophages uninfected or infected with M. avium at 
different MOIs. A) An example of the gating used in FlowJo to identify the CD4+ T cells, and 
investigate their cytokine production. Lymphocytes were gated using the FSC and SSC, followed by 
gating for CD3 and CD4. CD3+CD4+ T cells were then investigated for the production of IFNγ, 
TNFα, and IL2. B) T cells stimulated with Cell Stimulation Cocktail overnight, demonstrating T cell 
cytokine response and functional staining protocol. C) Shows the frequency of CD4+ T cells 
producing the cytokines IFNγ, TNFα, or IL2. CD4+ T cell effector cytokine production was analysed 
from unstimulated (no macrophages) 10 days expanded T cells, as well as overnight incubation with 
autologous macrophages that were uninfected, infected 3:1, or infected 10:1 with M. avium. Protein 
transport inhibitor was added for the last 4 hours of incubation to prevent cytokine excretion. Bars 
represent % of cytokine-producing cells within the gated CD3+CD4+ population as explained in the 
example in A). Black bars represent T cells that were generated from PBMCs expanded 1:1 with heat-
killed M. avium, and grey bars show the results for T cells expanded 3:1. Results obtained from one 
experiment.  
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4.4.2 Testing effector responses of expanded mycobacteria-specific T 
cells to autologous macrophages with different doses of M. avium 
infection  
Following establishment of mycobacteria-specific T cell expansion, we wanted to test which 
macrophage MOI that would result in the highest CD4+ TH1 effector cytokine production. 
Macrophages were differentiated and T cells expanded as previously described. On day 7-10 
macrophages were infected with live M. avium for 4 hours with different MOIs, and T cells 
were added for restimulation. The T cells were co-cultured with the macrophages overnight, 
and then stained and fixed for multicolour flow cytometry as described in Section 3.6. The 
frequency of CD4+ T cells producing each of the cytokines IFNγ, TNFα, and IL2 was 
measured and the results presented in Figure 4.6. Also here the fraction of CD4+ cells 
producing cytokines was relatively low, with the highest fraction around 0.5%. We 
experienced a big variation between different donors, as well as within each experiment. 
Despite the big variation, the trend was that a MOI of 10:1 gave the highest response, and we 
therefore chose to proceed with this MOI in further experiments. 
 
 
Figure 4.6: CD4+ TH1 effector cytokine production following restimulation of mycobacteria-
specific T cells with differently M. avium infected autologous macrophages  PBMCs were isolated, 
and T cells were expanded with heat-killed M. avium at a ratio of 3:1 for 10 days. Mycobacteria-
specific T cells were restimulated overnight with autologous macrophages uninfected or infected with 
M. avium at MOI 1:1, 3:1, and 10:1. The frequency of CD4+ TH1 cells producing each of the effector 
cytokines TNFα, IL2, and IFNγ, after exposure to macrophages infected with live M. avium at 
different MOIs overnight. The results are an average of 2-4 experiments using different donors, with 
each experiment having 1-3 replicates. Results are given as mean +/- standard deviation. 
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4.4.3 Kinetics of effector cytokine production from mycobacteria-
specific CD4+ TH1 cells after restimulation with M. avium 
infected macrophages 
As the cytokine response was low compared to expected results after overnight restimulation 
of the T cells, we wanted to investigate if earlier time-points allowed us to detect cytokines at 
a higher level. One experiment was carried out to investigate this. The macrophages and 
expanded mycobacteria-specific T cells were prepared as previously described. T cells were 
expanded with heat-killed M. avium at a concentration of 3:1 for 10 days, and macrophages 
were infected with M. avium at a MOI of 10:1 for 4 hours before T cell were co-cultured with 
the macrophages for restimulation. The time points tested for restimulation of mycobacteria-
specific T cells were 4, 8, 16, and 24 hours, followed by staining and analysis by multicolour 
flow cytometry. The protein transport inhibitor was added for the last 4 hours of the 
stimulation time. The results obtained from this experiment are presented in Figure 4.7. We 
see a higher cytokine production from CD3+CD4+ T cells (frequency of more than 1) of the 
TH1 cytokines IFNγ, TNFα, and IL2 at the earlier time points (4 and 8 hour restimulation 
time), followed by a decrease in production towards the previously used 24 hour restimulation 
time point. The frequency of CD4+ TH1 cells producing cytokines is also higher at these early 
time points compared to what has been obtained in previous experiments. T cells not 
restimulated show low cytokine expression, as expected (Figure 4.7). We would not expect T 
cells restimulated with uninfected autologous macrophages to show as high activation as 
those stimulated with infected macrophages. However, as seen in Figure 4.7, T cells 
restimulated with uninfected macrophages also induced a strong cytokine response (frequency 
of CD4+ cells of up to 7% for the 16 hour time point for IFNγ production), albeit somewhat 
slower than T cells exposed to infected macrophages. We thus cannot be sure if the cytokine 
response we see is mycobacteria-specific, or if the T cells are activated in response to other 
molecules on the macrophage surface. For previous experiments IFNγ has been the most 
produced cytokine; however, in this experiment TNFα had the highest induction. IL2 
induction had the lowest expression, which is consistent with previous experimental data 
(Figures 4.5 and 4.6).  
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Figure 4.7: The frequency of CD4+ T cells producing the cytokines IFNγ, TNFα, or IL2 at 
different times of restimulation with autologous M. avium infected macrophages.  PBMCs were 
isolated, and T cells were expanded with heat killed M. avium at a ratio of 3:1 for 10 days and 
restimulated overnight with autologous macrophages uninfected or infected with M. avium with a MOI 
of 10:1. Protein transport inhibitor was added for the last 4 hours of the total stimulation time. The 
solid lines represent T cells that have been restimulated with infected macrophages, and the dotted 
lines represent T cells that have been restimulated with uninfected macrophages. Production of the 
CD4+ TH1 effector cytokines IFNγ (blue), TNFα (red),and IL2 (green) was analysed 4, 8, 16, and 24 
hours after co-culturing with autologous macrophages. The unstimulated sample represents T cells that 
have not been restimulated with macrophages. Results obtained from one experiment with duplicate 
wells. Large variations were seen within each condition. 
Since a higher frequency of cytokine producing CD4+ TH1 cells was seen at 4 hours than at 
24 hours (Figure 4.7) one experiment was carried out where the T cells were restimulated for 
a total of 4 hours with macrophages infected with live M. avium with MOIs from 0.1:1 to 
100:1. We did not observe a higher frequency of CD4+ TH1 cytokine producing cells after 4 
hour stimulation than after 24 hour stimulation (data not shown).   
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5 Discussion 
Findings from the work carried out in this thesis suggest that Cul3 and Rbx1 are important for 
the KEAP1 mediated inflammatory regulation in M. avium infection in primary human 
macrophages, as knockdown of both Cul3 and Rbx1 resulted in an upregulation in 
inflammatory cytokines following M. avium infection. We also found that KEAP1 
knockdown downregulated the expression of HLA-DR and CD80 on the surface of primary 
human macrophages, independent of M. avium infection. These results implicate that KEAP1 
might play a role in regulating co-stimulation and antigen-presentation to CD4+ T cells. 
The oxidative stress sensor KEAP1 has various roles in the cell, including 
downregulation of NF-κB signalling54, links to autophagy52,87, and a role in inflammation55. 
KEAP1 has been shown to negatively regulate the inflammatory response and autophagy in 
response to infection with the non-tuberculous opportunistic pathogen M. avium in primary 
human macrophages
55
. The mechanism of how KEAP1 negatively regulates the inflammatory 
response to M. avium is still unclear, and was under investigation in this thesis. In particular, 
the roles of the E3 ubiquitin ligase complex proteins Cul3 and Rbx1 in regulation of 
inflammation in response to M. avium infection and possible roles of KEAP1 in antigen 
presentation were investigated.  
The transcription factor NF-κB is negatively regulated by KEAP1 through KEAP1 
dependent ubiquitination and hence degradation of IKKβ54. There is conflicting evidence 
about how IKKβ is inhibited. Proteasomal degradation, degradation through autophagy, and 
inhibition of phosphorylation have all been suggested as possible mechanisms
54,88
. Results 
from our group show that primary human macrophages produce ROS in response to infection 
with M. avium. We have also seen that knockdown of KEAP1 leads to an increased 
inflammation in response to mycobacterial infection, indicated through measurements of a 
range of cytokines produced both by activation of NF-κB and IRFs. Autophagy was also 
induced by M. avium infection, and autophagy increased in response to KEAP1 knockdown.  
This is the first time the role of KEAP1 in regulating inflammation and autophagy in response 
to M. avium has been reported
55
. 
Primary human cells are often time consuming and difficult to work with. Cell lines 
are often faster to work with, cells can be available at any time, and it is easier to get 
reproducible results independent of donor variations. HEK293 cells are easy to transfect and 
can be used to express proteins of interest
89
. We wanted to dissect the mechanism of how 
KEAP1 regulates the inflammatory response following mycobacterial infections. KEAP1 
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interacts with several proteins (including NRF2, p62, and the Cul3/Rbx1 complex), and a way 
to determine the role of each of these binding partners in inflammation is through systemic 
siRNA knockdown of each protein. HEK293 cells can in addition be transfected with 
plasmids containing mutated KEAP1 constructs where the interaction site of various proteins 
is removed to further dissect the mechanisms involved in inflammatory regulation by KEAP1. 
In addition, fewer experiments would most likely have to be carried out to obtain conclusive 
results, compared to work in primary human macrophages, as there are no donor variations 
that have to be taken into consideration. An example of how donor variation may affect 
results is seen in the experiments carried out in Section 4.2 where two experiments showed 
increased inflammation following M. avium infection when knocking down KEAP1, Cul3, or 
Rbx1, while one experiment showed a decreased inflammation following knockdown, 
although with a great variation between the duplicates.  All of these advantages would make it 
easier to unravel the mechanism of the KEAP1 regulated inflammatory response to M. avium 
using a cell line.  
We show in this thesis that siRNA treatment of HEK293 cells is effective already after 
48 hours, and these cells only require one siRNA treatment, compared to two treatments in 
primary human macrophages, saving both time and reagents using this system. HEK293 cells 
naturally express few TLRs on their surface, and we therefore chose to test a cell line that was 
stably transfected with TLR2 tagged with GFP. TLR2 was chosen, as it has been shown 
necessary for induction of NF-κB in response to mycobacterial infections90. Using different 
methods for testing both the induction of TNFα and activation of NF-κB in HEK293 cells 
showed a decreased inflammatory response in KEAP1 knockdown cells compared to controls 
following M. avium infection (see Section 4.1). A decreased inflammatory response following 
KEAP1 knockdown is the opposite of what has been shown in primary human macrophages, 
where a range of pro-inflammatory cytokines are more highly induced in KEAP1 knockdown 
cells compared to controls following M. avium infection
55
. Due to different inflammatory 
responses following M. avium infection in HEK293 cells and primary human macrophages, 
we believe that HEK293 cells are not a good model system for dissecting the mechanisms of 
how KEAP1 regulates inflammation in M. avium infection. One possible explanation for the 
different responses is that primary human macrophages express a range of PRRs, both on the 
plasma membrane and on intracellular membranes, many of which are important for both the 
recognition and phagocytosis of mycobacteria
19
, while some of these receptors may not be 
present in the HEK293 cells. Although TLR2 is shown to be important for NF-κB activation 
in response to mycobacteria
90
, many other receptors are also involved in the recognition of 
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mycobacterial antigens, and some of these may be responsible for the responses we see. This 
underlines the importance of always confirming findings in primary cells, as model systems 
might respond differently than the primary cells to various treatments.  
siRNA is a helpful method to study genes of interest, but there is also a risk of off-
target effects using this method, both at mRNA and protein levels
91
. The induction of 
interferon-stimulated genes has also been detected in response to siRNA, but there is 
contradictive evidence of this
92,93
. Different siRNAs targeting the same genes can induce 
divergent effects on off-target control gens
93
. Cleavage of the target mRNA occurs when there 
is a complete match between the siRNA and the target strand. However, there can be 
translational blockage of mRNA with less than perfect base pairing, which might also be a 
reason for off-target effects observed with some siRNAs
93
.  Due to these effects, one need to 
be careful when analysing siRNA data. We tested how siRNA treatment for each of our genes 
of interest (KEAP1, Cul3, and Rbx1) affected the expression of the untargeted genes (Figure 
4.3.A). At the mRNA level there was little off-target effect, and the siRNA to one partner of 
the complex did not influence the expression of the others. Although the siRNA treatments 
against KEAP1, Cul3, and Rbx1 did not appear to influence each other, we cannot say if the 
siRNA affects other genes related or unrelated to the inflammatory response. We observe an 
increase in the inflammatory response in uninfected cells treated with the non-targeting 
siRNA (AS), compared to untreated controls, suggesting that the siRNA on its own may 
induce some inflammatory response (data not shown). To try to correct for the unspecific 
siRNA induced inflammation, we chose to present data as the fold induction of cytokine 
expression of uninfected against infected cells given the same siRNA treatment. This would 
correct for the inflammation caused by each of the siRNAs. 
The mechanism of how KEAP1 is involved in regulating the inflammatory response is 
still unclear. After concluding that the HEK293 model system was not an appropriate system 
to investigate the mechanism behind how KEAP1 regulate inflammation in response to M. 
avium infection, the investigation was continued in primary human macrophages. KEAP1 
functions as an adaptor for Cul3-based E3 ubiquitin ligase
46
, and we wanted to investigate 
what role the E3 ubiquitin ligase proteins Cul3 and Rbx1 played in the inflammatory 
regulation following M. avium infection. This was carried out through knockdown 
experiments targeting each of the three genes KEAP1, Cul3 or Rbx1 as presented in Section 
4.3. In agreement with previous results the knockdown of KEAP1 gave higher induction of 
the cytokines TNFα, IFNβ, and IP10 compared to control samples following M. avium 
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infection in two independent experiments (Figure 4.3 B). The trend of higher inflammatory 
response appears to be the same for the cells with reduced expression of Cul3 and Rbx1. One 
experiment shows the opposite result, where the silencing of all three genes of interest showed 
lower cytokine induction following M. avium infection compared to control samples, although 
there were big variations within duplicates in this experiment. Variations in the inflammatory 
response to infection between experiments may in part be explained by the use of primary 
human macrophages (Figure 4.3 C). The use of primary cells means that every donor is 
different, and hence the variation between experiments can be expected to be bigger than with 
the use of a cell line. Several repeats were also required to allow our group to conclude upon 
the role of KEAP1 in inflammation
55
. The use of primary cells is still beneficial because it 
gives us more reliable insight into what actually happens in the human body, compared to the 
use of cell lines or mouse cells where the results may not always be transferrable to primary 
human cells. Previously the effect of knocking down NRF2 or p62 has been investigated in 
our group. Since KEAP1 serves as a negative regulator for the transcription factor NRF2
44,46
, 
one can speculate that a changed immune response following KEAP1 knockdown and 
infection might be due to the increased activity of NRF2. However, knockdown of NRF2 
gave an inflammatory response comparable to control cells following M. avium infection
55
. 
The selective autophagy substrate p62 can bind and inactivate KEAP1
52
, and KEAP1 is 
indicated to be degraded through autophagy in a p62 dependent manner
94
. p62 knockdown 
has shown a decreased induction of inflammation in response to M. avium infection 
(unpublished data). We can speculate that KEAP1 accumulates in p62 depleted cells due to 
less inactivation and degradation, and hence the inflammatory response is decreased. 
However p62 has also been reported to have a direct negative regulatory effect on activation 
of NF-κB95, which would suggest a higher inflammatory induction in the absence of p62.  
The preliminary findings presented here indicate that knockdown of Cul3 as well as 
Rbx1 gives the same results as knockdown of KEAP1. It can be speculated that the 
ubiquitination carried out by the E3 ubiquitin ligase complex is an important factor in the 
regulation of the inflammatory response. We cannot conclude that knocking down Cul3 or 
Rbx1 gives the same increase in inflammatory response as knocking down KEAP1, and more 
repeats of the experiment is needed to determine this. There is however reason to believe the 
outcome is the same, as the two experiments showing expected results for KEAP1 
knockdown also showed increased inflammatory response in Cul3 and Rbx1 knockdowns 
(Figure 4.3 B). Lee et. al.
54
 focused on the role of KEAP1 in cancer, and saw that there was a 
high percentage of genome loss or mutations in the genes encoding KEAP1, Cul3, and Rbx1 
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in cancers that did not degrade IKKβ. They suggest KEAP1 induction may be a target for 
drug development as it influences the expression of both IKKβ and NRF2, which unregulated 
may lead to cancer or chemotherapy resistance. However, in infection with M. avium KEAP1, 
Cul3, and Rbx1 all seem to be beneficial for the bacteria and not the host, as decreasing the 
expression of these genes increases the inflammatory response. KEAP1 also decreases the 
intracellular survival of the bacteria
55
. These results taken together suggest that the ubiquitin 
machinery associated with KEAP1 is important both in the regulation of cancer development 
and in regulation of inflammatory responses. Using KEAP1 as a target for drug development 
might be promising, however it is important to take into consideration that KEAP1 appears to 
be beneficial for the survival of some pathogens, as demonstrated with M. avium.   
For the detection of cytokines following stimulation of cells, we measured the mRNA 
level using real-time PCR. This gives us information about the transcriptional level of genes, 
which might not always correlate with protein levels. Studies show varying results regarding 
this issue, and different cytokines show different correspondence between cytokine mRNA 
and secreted protein levels in animal models
96,97
. A study using human cells suggests a good 
correlation between mRNA and protein levels of some cytokines (including IFNγ, TNFα, and 
IP10), while other cytokines did not show correlation
98
. These data suggest that the 
expression measured at the mRNA level does not always reflect the protein expression. A 
comparison of the mRNA levels and protein expression measuring cytokine responses 
following M. avium infection has previously been carried out in our lab, and showed good 
correlation. Due to these previous results suggesting good correlation between protein and 
mRNA levels only real-time PCR was carried out to measure cytokine expressions in this 
thesis. Other methods that could be used to confirm results from the mRNA analysis include 
measuring protein levels by enzyme-linked immunosorbent assay (ELISA) or western 
blotting. 
Measurements of knockdown efficiency were also done by real-time PCR. Also here 
there might not be concordance between the levels measured at the mRNA level and the 
actual presence of proteins. KEAP1 has been measured to have a half-life of 12.7 hours in 
resting cells, which goes down following electrophilic stress in an autophagy dependent 
manner
94
. The siRNA treatment in the primary MDMs lasted for 72 hours, and we can 
therefore assume that low mRNA levels reflect low protein levels. Previous results from our 
group have also showed a good correlation between mRNA and protein levels following 
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knockdown with siRNA. Real-time PCR is a good method when starting an investigation of 
new proteins, as it is relatively quick and can give an indication of the protein expression.  
HLA-DR is a MHC class II protein and CD80 is a T cell co-stimulatory molecule, 
both found on the surface of APCs. Their expression becomes upregulated when APCs comes 
into contact with antigens. Both of these molecules are required for the stimulation and 
activation of specific CD4+ T cells
59
. Since KEAP1 has been shown to play a role in 
inflammation following M. avium infection
55
, and M. tuberculosis has been shown to 
downregulate the expression of MHC class II molecules on the surface of macrophages
18
, we 
wanted to investigate if KEAP1 influenced the antigen-presentation following M. avium 
infection in primary human macrophages. Any changes in the surface markers might 
influence the activation of the adaptive immune system, specifically CD4+ T cells. It appears 
that the knockdown of KEAP1 alone decreased the expression of both HLA-DR and CD80 
with approximately 20% (Figure 4.4 B). In the presence of M. avium infection, the expression 
of both CD80 and HLA-DR was somewhat increased in the KEAP1 knockdown cells. These 
results suggest that KEAP1 has a positive role on expression of molecules associated with 
antigen presentation. The mechanism behind how KEAP1 influence the antigen presentation 
and how M. avium affects this is not known, but there can be several possibilities as KEAP1 
is a molecule with many interaction partners involved in various cellular mechanisms. We 
might speculate that autophagic processes are involved.  
Autophagy is a defence mechanism that is shown to contribute to antigen presentation, 
decrease intracellular survival, and increase the adaptive immune response to M. tuberculosis 
infections
35,38,39
. Our group has provided evidence suggesting that M. avium induces 
autophagy
55
. Autophagy was induced already at 4 hours of infection, and sustained up to 72 
hours post infection. As autophagy is induced by M. avium, and induction of autophagy has 
been shown to increase peptide presentation and T cell responses to M. tuberculosis
39
, we 
might expect the expression of HLA-DR and CD80 to increase in response infection with this 
pathogen. The presence or absence of infection did appear to affect the levels of HLA-DR and 
CD80 to some degree, by decreasing the difference in expression seen between control cells 
and KEAP1 knockdown cells, however no significant difference was seen between control 
cells (siAS) and infected control cells (siAS infected) (Figure 4.4 B). 4 hours of infection has 
been shown to be enough to induce autophagy, but it is possible that more time is needed to 
see the change in antigen-presentation. Further experiments should aim at investigating CD80 
and HLA-DR expression at different time points post M. avium infection +/- knockdown of 
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KEAP1. KEAP1 has previously been reported to have a positive role in autophagy regulation 
for ubiquitin aggregate clearance
87
. Results from our lab, however, suggest that KEAP1 may 
negatively regulate autophagy in M. avium infected in human macrophages
55
. These 
conflicting results make it hard to draw any conclusions.  
We are looking at isolated pathways when investigating the effects of knocking down 
KEAP1, and many factors outside of our focus may influence our findings. Uncontrolled 
inflammation can be damaging to the cells, and mechanisms to control this are needed. 
Knocking down KEAP1 leads to increased pro-inflammatory cytokine production
55
. It might 
therefore be possible that KEAP1 on the other hand downregulates the stimulatory molecules 
needed for T cell activation in order to avoid excessive inflammation. We do, however, not 
know how much the downregulation of HLA-DR and CD80 that we see would affect the 
following acquired immune response and CD4+ T cell activation. If KEAP1 positively 
regulates the expression of the two proteins HLA-DR and CD80, it would be interesting to see 
how induction of KEAP1 changed the expression of these two molecules. If an induction of 
KEAP1 leads to an increase in expression of HLA-DR and CD80 on the surface of primary 
human macrophages, this could be a possible target to increase vaccine efficiency through 
increased T cell activation. Again, it is important to take into consideration the positive role 
KEAP1 appears to have in survival of intracellular M. avium
55
. In order to understand if and 
how KEAP1 affects the activation of mycobacteria-specific CD4+ T cells, experiments where 
mycobacteria-specific T cells were expanded, and restimulated with M. avium infected 
autologous macrophages were carried out. 
The protection provided by mycobacteria-specific CD4+ TH1 cells is essential for the 
host defence against pathogenic mycobacteria such as M. tuberculosis. It has also been shown 
that the presence of multifunctional CD4+ T cells simultaneously producing the cytokines 
IFNγ, TNFα, and IL2 reduce the burden of mycobacteria74. Knowing this we wanted to 
investigate the activation and cytokine production of CD4 TH1 cells specific to M. avium, in 
response to M. avium infected human primary macrophages. We also wanted to investigate if 
KEAP1 knockdown in the macrophages would affect the T cell activation, as we observed a 
downregulation of the surface proteins HLA-DR and CD80 on the surface of primary human 
macrophages following KEAP1 knockdown.  
Before we could investigate the T cell activation, there was a need to establish the 
method for expansion and restimulation of specific T cells. Different conditions for both 
expansion and restimulation were tested out, trying to identify the optimal conditions for our 
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investigation. T cells were able to get activated and produce cytokines, as demonstrated using 
a positive control (Figure 4.5 B). This indicates that the T cells were alive and able to be 
activated upon stimuli. It also gives an indication that the staining protocol for flow cytometry 
was functioning, as cytokines were stained and detected in these samples (Figure 4.5 B). As 
demonstrated in Section 4.4, we were not able to obtain a cytokine response at the level we 
expected, and the response was relatively low with mostly around 0.5% of CD4+ T cells 
producing either cytokine tested. Stimulation of expanded T cells with uninfected 
macrophages gave comparable cytokine production as stimulation with M. avium infected 
macrophages in some experiments.  In the kinetics experiment, where the cytokine response 
from T cells was tested at different time points, we saw that uninfected macrophages also 
induced a cytokine response, although this response is somewhat slower than with the 
infected macrophages. This unspecific activation may be due to unspecific interactions with 
the macrophages. In in vitro experiments, conditions are never optimal for the cells, and some 
cells will be in distress or dead. Signals from these cells may be enough to activate T cells. 
Cells were assessed by microscopy before the start of each experiment, and were not used 
unless they looked healthy. We also had problems with large variations both between 
different donors and within biological replicates from the same donor. The variation between 
donors can in some part be explain by the fact that we were working with primary human 
cells, and that cells from different donors will always wary in their response to different 
stimuli. There may also have been some differences in the number of macrophages per well, 
leading to different numbers of cells presenting antigens for T cell stimulation.  
The low cytokine response may be due to an inability to expand the T cells specific for 
the pathogen of interest. As mentioned above, from unexpanded T cells only a low fraction of 
the cells would recognise antigens presented from the M. avium infected macrophages, which 
could explain the low fraction of CD4+ T cells producing cytokines. Several parameters were 
tested out to attempt to increase the expansion, without luck. Other parameters that could be 
tested out for a better expansion include changing the ratio of PBMCs for expansion, 
changing the ratio of T cells to macrophages upon restimulation, addition of less or no IL2 
during the expansion step, longer expansion time, or using Purified Protein Derivative (PPD) 
from mycobacteria for expansion of specific T cells instead of heat killed M. avium. We could 
also measure the levels of cytokines in the supernatant using ELISA.  
One of our aims was to look at the fraction of multifunctional CD4+ TH1 cells producing 
all three cytokines IFNγ, TNFα, and IL2 in response to M. avium infected autologous 
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macrophages. However, due to the low response for each cytokine, the fraction of 
multifunctional T cells could not be addressed in this work. In order to carry out this 
investigation, the protocol for expansion and restimulation of specific T cells must be 
optimised further, to allow solid analysis of T cell activation and cytokine production in 
response to stimulation with M. avium infected autologous macrophages. If a functional 
protocol is established it would also be interesting to investigate the effect of mycobacteria-
specific CD4+ T cells on the intracellular killing of M. avium in the infected autologous 
macrophages.   
60 
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6 Conclusion  
Looking at evidence obtained previously and results from this thesis, there is little doubt that 
KEAP1 plays a role in the host defence against the opportunistic pathogen M. avium. KEAP1 
appears to play roles in the inflammatory response in macrophages following M. avium 
infection by downregulating the following cytokine response
55
. The mechanism underlying 
the KEAP1 regulation of inflammatory responses and autophagy is still unclear. 
We concluded that HEK293 cells are not a suitable model system for dissecting the 
mechanisms behind how KEAP1 regulates the inflammatory response following M. avium 
infection. Primary human macrophages were therefore used for the investigation. Findings 
from the work done in this thesis indicate that the ubiquitination machinery associated with 
KEAP1, including the proteins Cul3 and Rbx1, play an important role in the KEAP1-
mediated regulation of inflammatory responses to M. avium infection.  
Furthermore, the results presented here add evidence that KEAP1 might also play a 
positive role in antigen presentation. We found that the expression of CD80 and HLA-DR 
were approximately 20% downregulated when KEAP1 was knocked down in primary human 
macrophages. How KEAP1 positively influence the two molecules CD80 and HLA-DR and if 
this might have consequences for mycobacteria-specific T cell activation could not be 
determined in this study. 
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7 Future perspectives 
HEK293 cells were not found an appropriate model system for dissecting the role of KEAP1 
in inflammatory regulation in response to M. avium, as they responded differently compared 
to primary human macrophages. Other cell lines should be examined to establish a good 
model system for further analysis of KEAP1s involvement in inflammation. With a suitable 
model system that allows knockdown of endogenous KEAP1 as well as transfection with 
differently mutated variants of the gene, the dissection of how KEAP1 regulates inflammation 
in response to M. avium infection can be further investigated.  
Through this project we have obtained preliminary results suggesting that the ubiquitin 
machinery (Cul3 and Rbx1) associated with KEAP1 is important for the regulation of 
inflammation following M. avium infection in primary human macrophages. Knockdown of 
these two genes prior to infection give a similar inflammatory response as knockdown of 
KEAP1. More repeats of the experiment should be carried out in order to conclude upon this. 
If these molecules are proved to be central in the regulation of inflammation, further research 
should be carried out to identify the targets for ubiquitination and how these are degraded. If 
KEAP1 regulates degradation of central inflammatory signalling molecules, this can also have 
implications for other systems. If this is the case, the regulation we see is probably not 
mycobacteria-specific, but can also be important for other infections and inflammatory 
conditions where the same signalling pathways are involved.  
Evidence obtained here suggests that KEAP1 positively influences the expression of 
CD80 and HLA-DR, both molecules that are involved in antigen-presentation and activation 
of CD4+ T cells. How KEAP1 positively influences expression of these two molecules in 
human macrophages is not known and more research should be undertaken to investigate this.  
It is not known if KEAP1’s effect on expression of molecules involved in antigen-
presentation, as well as its effect on inflammation in response to M. avium infection has an 
impact on subsequent activation of a mycobacteria-specific adaptive T cell response. In this 
work, we tried to establish a model system that would allow analysis of the activation of 
expanded mycobacteria-specific T cells in response to stimulation with autologous 
macrophages in vitro. More experiments are necessary to optimise this model system. So far 
we can only speculate that KEAP1 knockdown has an inhibitory effect on the antigen-specific 
CD4+ T cell activation, and future work will show how KEAP1 in innate immune cells 
affects the adaptive immune response.  
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9 Appendix  
Appendix 1: siRNA additional information 
KEAP1 siRNA sequences 
Name Catalog no. 
Hs_KEAP1_5 SI03246439 
Hs_KEAP1_7 SI04267886 
Hs_KEAP1_6 SI04155424 
Hs_KEAP1_2 SI00451675 
 
Cul3 siRNA sequence 
Name Catalog no. 
Hs_CUL3_5 SI02225685 
Hs_CUL3_8 SI03030160 
Hs_CUL3_10 SI04379963 
Hs_CUL3_2 SI00053347 
 
Rbx1 siRNA sequence 
Name Catalog no. 
Hs_RBX1_5 SI02654190 
Hs_RBX1_6 SI02654316 
Hs_RBX1_3 SI00700525 
Hs_RBX1_9 SI04438469 
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Appendix 2: Staining for flow cytometry  
Extracellular staining 
All samples for flow cytometry were transferred to polystyrene tubes, where the staining and 
fixation steps occurred, followed by running the sample. Flow wash is a solution with PBS 
containing 2% FCS. 
1. Label polystyrene tubes appropriately, and add 1 ml of flow wash to all tubes. To kill 
any live bacteria, 0.05% NaN3 was added to the wash buffer at this first stage.  
2. The appropriate sample was added to the labelled tubes. 
3. The tubes were centrifuged at 528 RCF for 5 minutes, and the supernatant was 
discarded by decanting.  
4. Extracellular staining step: 1 µl of each extracellular stain was added to each tube. For 
convenience, all extracellular stains were added to an Eppendorf tube and made up to 
a final volume of 10 µl using flow wash. One “colour mix” was made for all samples. 
10 µl of the mix was added to each of the tubes, which were then vortex and left on ice 
for 15 minutes protected from light. 
5. To remove any unbound stain, 1ml flow wash was added per tube, and centrifuged at 
528 RCF for 5 minutes. 
6. The supernatant was discarded by decanting, followed by fixation. 500 µl of 2% 
paraformaldehyde (PFA) per tube was diluted in PBS from a 16% stock. The tubes 
were vortexed and incubated at room temperature for 15 minutes, protected from light.  
7. Samples were centrifuged at 528 RCF for 5 minutes, and the supernatant removed. 
8. The samples were resuspended in approximately 1 ml wash buffer by vortexing. The 
extracellular staining was now complete, and the samples were further used for: 
I) Flow cytometry analysis, or 
II) Extracellular staining (see step 9 and on) 
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Intracellular staining 
9. The samples that had been extracellularly stained were centrifuged at 528 RCF for 5 
minutes.  
10. The supernatant was removed and the samples were resuspended in 1 ml wash buffer, 
and centrifuged again, using the same settings as above.  
11. The supernatant was removed by decanting. In order to be able to stain the cells 
intracellularily they had to be permeabelised. This was accomplished by using 
saponine. The samples were resuspended in 500 µl of flow wash with 0.5% Saponin. 
12. Samples were centrifuged at 528 RCF for 5 minutes. The supernatant removed, and 
cells were resuspend by vortexing in the 0.5% saponin solution again, and incubated 
for 5 minutes at room temperature.  
13. Samples were centrifuged at 529 RCF for 5 minutes the supernatant discarded. 
14. Intracellular staining: A “color mix” was prepared as for the extracellular staining (see 
step 4). 10 µl of the mix was added per sample, and the cells left to incubate for 30 
minutes at room temperature, protected from light. 
15. The samples were then washed twice by addition of 1ml wash buffer followed by 
centrifugation at 528 RCF for 5 minutes and discarding the supernatant between.  
16. The samples were resuspend in 0.5 ml of wash buffer and were now ready for flow 
cytometry analysis. The samples can be stored overnight at 4°C, protected from light. 
 
